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ABSTRACT 
Background: Thymoquinone (TQ) is one of the most active ingredients of Nigella sativa 
seed. TQ has a variety of pharmacologic properties including possess antinociceptive, 
antibacterial, anti-inflammatory, anti-oxidative activities and osteogenic effects on bone 
cells. Because of these properties, TQ might play an important role in odontogenic effects 
on human dental pulp cells and be used as a pulp capping material. 
Purpose: This study evaluates the effect of TQ on the attachment efficiency, 
proliferation, and odontogenic differentiation of Human Dental Pulp Cells (HDPC's). The 
effect of TQ on odontogenic differentiation was also determined by evaluating alkaline 
phosphatase (ALP) activity and Dentin Sialoprotein (DSP) expression. 
Methods: Human dental pulp cells were cultured in triplicate using growth media with 
various TQ concentrations: 5 μM, 10μM, 15μM, 30μM, and 0μM as a control group at 7 
and 21 days.  Crystal violet staining was used to determine cell attachment efficiency and 
cell proliferation. The proliferation rates were normalized to cell numbers of each group 
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at 16 hours. Cell differentiation was assessed by evaluating ALP activity and DSP 
expression. The data were normalized on per million cells basis. Univariate analyses 
including ANOVA and Student’s t-test were conducted. 
Results: Higher cell attachment efficiency was shown in all TQ groups at 16 hours (P<. 
0001) except for the 5 μM group. A significantly higher cell proliferation rate was shown 
with low TQ concentration 5 μM at 7 days (P<. 0001) and at 21days (P<. 0.05). 
However, the cell proliferation rates decreased significantly with higher TQ 
concentrations at both time intervals (P< 0.0001). Similarly, prolifration rates decreased 
at 21 days TQ =10 μM (P< 0.0001) and TQ =15 μM (P=0.0006). Significantly higher 
levels of alkaline phosphatase activity were observed in all TQ groups at 7 days (P 
<0.0001) and at 21 days (P <0.0001). Dentin sialoprotein expression was significantly 
down regulated in all TQ groups at 7 days compared to the control (P <0.05), however, at 
day 21 only TQ =15 μM exhibited significant down regulation of DSP compared to the 
control (P <0.0001). 
Conclusion: All tested TQ concentrations significantly enhanced cell attachment 
efficiency at 16 hours except TQ =5 μM. Cell proliferation rates were increased 
significantly by low TQ concentration 5 μM, and decreased significantly with higher TQ 
concentration 30 μM at 7 and 21 days. TQ exhibits odontogenic potential by inducing a 
significant increase in ALP activity at 7 and 21 days. TQ did not have any effect on DSP 
expression at 21 days except TQ =15 μM which signficantly decreased DSP expression. 
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Chapter One: Introduction and Background 
 
1.1: Alternative Medicine: 
Organic and natural medicines have been utilized widely in the dental and therapeutic 
field for close to ten years now. What's more, these medications have become more 
prevalent today due to their various benefits such as antimicrobial activity, anti-
inflammatory action, biocompatibility and anti-oxidant properties1.  Natural drugs come 
from plants and are also called alternative medicine. For a considerable length of time, 
human beings have used natural medications for prophylaxis and cure of sicknesses. 
However, the magnitude of the impact of natural medications on oral tissues, their 
workings and after effects is still not clearly understood by health experts2. Clarity is 
important when a product gains wide acceptance. Currently, the trend in the medical field 
is shifting from pharmaceutical medications to herbal products as a way to deal with 
ailments. Due to this trend, numerous natural medications are being advertised for oral 
and dental use. Alternative medicine might either be dental medications with natural 
elements or herbal drugs. Depending on their use, herbs are included in a number of 
dental drugs, for instance: Bloodroot, Caraway, Chamomile, Echinacea, Peppermint, 
Rosemary, Thyme, Aloe Vera, Green tea, Fennel, Ginger, Salvadora persica (miswak 
extract), Clove oil, Eucalyptus and Nigella sativa oil 3.  Bad oral cleanliness brings about 
plaque build-up, which is a common etiological variable in the existence of dental caries, 
gingival, and periodontal infections. One proven remedy for bad mouth odors is herbal 
toothpaste.  For example, types of toothpastes that contain Aloe Vera extracts have been 
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found to lower plaque aggregation and get rid of gingival ailments. Similarly Sanguinaria 
extract, derivatives of Sanguinaria Canadensis (bloodroot) in toothpastes has also proved 
effective in the control foul mouth odor. Natural mouthwashes and kinds of toothpaste 
which have miswak extract are also known to reduce plaque formation and gingival 
aggravation4. Another notable natural extract used in dental care is Green tea. It has 
important ingredients, for example, polyphenols, which have disease-preventive, anti-
inflammatory, and anti-cariogenic impacts. Green tea is used to make mouthwash 
because it shows that same viability as chlorhexidine in diminishing cariogenic 
microscopic organisms and the acidity of plaque and saliva5. Nigella sativa extracts have 
also been utilized for their restorative benefits, some of which include, immune-
potentiating activity, hypotensive, analgesic, antibacterial, anti-inflammatory, antifungal, 
antioxidant, and anticancer properties6. In dentistry Nigella sativa has been discovered to 
have a mitigating impact on the oral health and thus accordingly utilized as pulp medicine 
in health practice7. In spite of a few natural items that have been tested, the evidence is 
not great enough to warrant widespread usage. Health professionals and researchers need 
to carry out more tests to demonstrate the adequacy and safety of dental medicaments 
made from alternative medicine. Such investigations will give both dentists and patients 
the clinical proof on the advantages of herbal medicines and encourage them to use 
Nigella sativa for a therapeutic purpose.  
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1.2: Nigella sativa seed: 
Nigella sativa is an annual herbaceous plant affiliated with the Ranunculaceae 
family. It also has other aliases e.g. black cumin (English), black-caraway seeds (U.S.A.), 
habba-tu sawda (Arabic), kalonji (Urdu and Hindi), krishnajirika (Sanskrit), kalajira 
(Bangali) and shonaiz (Persian)8. The plant originates from the Middle East and 
southwest Asia. Nigella sativa grows to between 20 and 90 cm tall and has a colorful 
appearance. The pips have medicinal properties, with thymoquinone (30% – 48%) being 
the main healing constituent in the plant9. Nigella sativa has bluish white, faded, yellow, 
and isolated flowers (photo1). The final fruit is capsule-like and has numerous rectories. 
Pips are tiny, dicotyledonous, trigonous black, and rugulose-tubercular10. 
The oil found in Nigella sativa has been utilized for a considerable length of time 
as both a nourishment additive and alternative medicine for sicknesses such as asthma, 
hypertension, diabetes, cough, bronchitis, headache, eczema, dizziness, and flu (figure1) 
11, 12. Other parts of the plant including the seed are sometimes utilized as a carminative, 
diuretic, lactagogue, and vermifuge13. Nigella sativa has been broadly used to treat 
sensory system ailments like memory impairment, epilepsy, neurotoxicity, and pain 14. 
Although the literature research of previous investigations is preparatory and limited, the 
outcome uncovered that the dark seed plants possess a restorative characteristic for oral 
and dental infections 15. 
Nigella sativa has been found to have thymoquinone, thymohydroquinone, 
dithymoquinone, thymol, carvacrol, nigellimine-N-oxide, nigellicine, nigellidine, and 
alphahederin 16. Scientists first discovered the healing characteristics of the phenolic  
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portion of Nigella sativa in 196517. Likewise, extracts of Nigella sativa were found to 
have a good impact on multi-drug–resistant pathogens, including gram-positive and 
gram-negative microscopic organisms 18. 
 Safety is an issue when it comes to experimental drugs. Luckily, both the seeds 
and the oils of Nigella sativa do not have any significant side effects11. The animal 
models of distinctive ailments where TQ has been examined in distinctive dosage ranges 
indicates a guaranteed preventive and restorative agent, enriched with advantageous 
impacts with non-harmful toxicities19 ,20, 21. Test outcomes indicate that when Nigella 
sativa is administered orally at a dose of 2 mL/kg body weight for a period of about 28 
days, it brings about zero transformation in liver protein levels and has no poisonous 
impacts on the liver function in serum AST, ALT and ALP levels after treatment of 
normal healthy rats 22. Additionally, the poisonous quality of Nigella sativa fixed oil 
(NSFO) has been tested in mice and rats through the determination of LD50 values and 
scrutinization of biochemical, hematological, and histopathological progressions. The 
results of the experiment showed no progressions in the levels of hepatic enzymes, 
including AST, ALT, GGT, and no histopathological adjustments (heart, liver, kidneys, 
and pancreas) on the test subjects. However, serum levels of cholesterol, TG, glucose, 
and the number of leukocytes and platelets diminish significantly, contrasted with control 
values, as hematocrit and hemoglobin levels increase fundamentally. The outcomes 
indicate that the low poisonous quality of NSFO is affirmed by rising LD50 values, 
important hepatic enzyme stability, and organ integument. Consequently, the safety of 
NSFO doses is proven and medical professionals can recommend it for patients, however, 
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the changes in hemoglobin metabolism and the fall in leukocyte and platelet tallies have 
to be considered when giving out such prescriptions23. In fact, high doses of Nigella 
sativa essential oil (NSO) have detrimental impacts on the histological composition of the 
kidneys and to a lesser degree on the liver. Therefore, NSO should be used in proper 
quantities, and further studies are recommended24.  
 
1.3 Thymoquinone: 
 1.3.1:Thymoquinone, definition and properties 
Thymoquinone (2-Isopropyl-5-methylbenzo- 1,4-quinone) (photo1) is the bioactive 
constituent of the unstable oil for Nigella sativa. Researchers have studied it using both  
in vitro and in vivo models ever since its initial extraction in the 1960s. Regardless of its 
restorative characteristics, the requisition of TQ is constrained because of its 
physicochemical features. Hydrophobicity and insolubility bring about poor 
bioavailability and necessitate a requirement to create a suitable plan 25. Furthermore, TQ 
is sensitive to light, temperature and pH with minimal degradation at acidic pH levels26. 
Some writers have widely reviewed Nigella sativa and its active component, TQ, and 
discovered their pharmacological impacts on the body. Current reports highlight the anti-
inflammatory, anti-microbial, anti-cancer, antioxidant, antidiabetic, and anti-hypertensive 
characteristics of the plant27. This research will concentrate on the oral wellbeing and the 
integument of the oral cavity, which is important for the general wellbeing of people. 
Oral sicknesses are preventable, and for several years, the utilization of plants, oral well-
being care, and restorative improvements have been closely related28, 29. Previous 
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research demonstrates that thymoquinone has powerful anti-oxidant impacts through its 
superoxide searching capability. This ability is recognized as one of the most significant 
properties of TQ30. Oxidative anxiety is an anomaly that comes about due to an absence 
of harmony between the intracellular generation of free radicals and the antioxidants that 
control oxidative responses by hindering, delaying or hampering the oxidation of 
substances. This disequilibrium between pro-oxidants and antioxidants is disturbed by an 
expansion in the amount of spare radicals, or a diminishment in the amount of anti-
oxidative substances, and can sometimes bring about lipid peroxidation, DNA harm, and 
the debasement of cell division proteins. Therapeutic research has shown that incendiary 
diseases, including diabetes mellitus, atherosclerosis, and chronic inflammatory lung 
disease, are associated with oxidative stress31.  
1.3.2:Thymoquinone and general body health  
The utilization of natural pills as alternative medicine is predominant and receiving 
global ubiquity. A significant number of pills contain plant elements; at the same time, 
others are artificially altered with organic ingredients. Research articles published so far 
demonstrate the pharmacological merits of Nigella sativa seeds and some of its elements, 
especially TQ and alpha-hederin, which have amazing in vitro and in vivo 
pharmacological characteristics against an expansive array of sicknesses6. Therefore, TQ 
is generally safe and good for general body health due to its healing capabilities against a 
wide variety of illnesses.   
Nigella sativa has been examined for a long time by researchers due its therapeutic 
characteristics 6. It exhibits a range of healing properties: for example, diuretic, 
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antidiabetic, antihypertensive, antimicrobial, gastroprotective, antioxidant, and renal 
protective. Nigella sativa seeds are broadly utilized as medicine to treat sicknesses such 
as asthma, bronchitis, diarrhea, and skin issues6. It may be likewise utilized as a liver 
tonic, hunger stimulant, digestive aid, to extend milk generation for nursing moms, as a 
way to battle parasitic infections, and to back the body's immune framework. A large 
portion of the restorative properties of this plant are credited to TQ, which is a compound 
present in the plant.  
1.3.3 Thymoquinone and oral health  
1.3.3.1:Thymoquinone and plaque formation 
Thymoquinone has demonstrated a secondary potency to forestall bacterial biofilm 
creation by diminishing the metabolic oxidative action of the cells. Additionally, it 
possesses a powerful growth-inhibiting action against gram-positive microscopic 
organisms with least inhibitory fixation (MIC, which is characterized as the concentration 
that totally hindered unmistakable cell development during a 24 hrs. brooding time at 
37°C) going from 8 to 64 g/mL32, 33. Additionally, thymoquinone prompted a particular 
antimicrobial action against oral pathogens; its synergistic impact brought about no less 
than a 4-fold potentiation of the tested antibiotics and antiseptics34. Streptococcus mutans 
remains the main pathogen found in dental caries. Its pathogenicity is because of the 
creation of extracellular polysaccharides and its capability to tie to dental tissues through 
a biofilm and subsequent plaque formation35, 36. The microbiome is made from salivary 
glycoproteins, microscopic organisms (cocci, bacilli, and filamentous forms) and their 
metabolic end results orchestrated over a grid of extracellular material. Dental 
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microbiome aggregates on and adheres to the teeth, restorations and prosthetic appliances 
in the mouth, and assumes a paramount role in oral and dental infections37. Natural 
medications have as of late been investigated as potential alternatives to engineered 
antimicrobial drugs, including herbal items, for example, Nigella sativa and TQ38.29, 39.  
1.3.3.2 Thymoquinone and dental caries 
 TQ has anticariogenic characteristics against S. mutans, and this may be good for the 
prevention and treatment of dental caries. Thymoquinone stops dental plaque 
development at a concentration of under 100 µg/mL (IC50 =20 µg/mL)40. In spite of the 
fact that analysts have confidence that Nigella sativa and TQ have a part to play in caries 
aversion due to its antibacterial properties, there have been only a couple of published 
investigations on this subject. One case was done with a rodent test model. Its point was 
to examine the impact of NS on caries commencement through the restraint of 
microbiome arrangement. In that study, the animals were tested for s. mutans and given 
an eating regimen composed mainly of sucrose. The outcomes indicated that the rats’ 
medication with 10 mg of TQ per kg of body weight in oral gel or drinking water 
statistically decreased their caries scores (p=0.02) and plaque indicator (p=0.01) in an 
examination of the control groups. Those researchers attributed the decline in dental 
caries to the microbial biofilm restraint properties of TQ38 
1.3.3.3: Thymoquinone as a dental pulp capping material 
Another experiment looked for a contemporary capping medicament in pediatric 
dentistry to replace Formocresol due to its reported side effects. The study contrasted the 
histopathological pulp reaction to Nigella sativa oil and formocresol (FC) in canines. The 
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results revealed that NS specimens histologically showed mild to moderate vasodilatation 
with few inflammatory cells and a continuous odontoblastic layer. On the other hand, FC 
specimens exhibited advanced swelling with extreme vasodilatation and inflammatory 
cell infiltration and degeneration. Thus, using Nigella sativa retained the viability of the 
pulp, which makes it a good pulpotomy adjunct in clinical practice7. 
1.3.3.4: Thymoquinone and periodontal disease 
TQ also warded off periodontal aggravation and diminished alveolar bone 
misfortune in tests of periodontitis in rats41. Another experiment showed a potential pre-
emptive role of TQ on gingival swelling. The results revealed that rats that were given 
TQ by drinking water or via an oral gel experienced statistically moderate periodontal 
indices and sub gingival bacteria counts when compared to both the negative and positive 
control groups. Additionally, the mandibular tissues of the rats, which were extracted for 
histopathology scrutiny to figure out the level of inflammation, exhibited zero signs of 
infection compared with the controls38 
1.3.3.5: Thymoquinone and dental implants 
To conclude, thymoquinone is a generally safe compound, especially offered 
orally to rodents. TQ also has no effects on human beings. 11, 42. Examining other 
properties, an in vivo study was carried out to find out black seed oil extract’s effect on 
the bone implant interface’s mechanical and histological properties. In that experiment, a 
researcher attached 4 screw-shaped (84 CpTi) implants in the tibiae bone of 12 New 
Zealand rabbits. The artificial inserts were split into 2 categories: coated with black seed 
oil extract and uncoated. The outcome of the experiment showed that over time, coated 
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implants had notably better torque resistance than the uncoated ones, and histopathology 
results showed earlier osseointegration with an osteophilic surface, as well as lack of 
unfavorable tissue reaction43.  
1.3.3.6: Thymoquinone and bone formation  
Some researchers recommend natural herbs as a coating agent because the 
biological particles improve osseointegration in dental inserts44. But current research on 
Nigella sativa and bone healing is conflicting. One study, conducted by El-Sweify et al.45, 
to identify the effect of calcium hydroxide powder blended with NS oil contrasted with 
bioglass on the therapeutic effects of mandibular bone defects in rats did not turn out as 
expected. The investigation involved 40 albino rats subjected to surgical operations to 
create a mandibular surgical defect. The rodents were then divided into 4 groups. Group I 
was the control group, where the bony imperfections were left unaltered; Group II had 
bony defects which were packed with calcium hydroxide powder merged with saline; 
Group III had bony defects loaded up with calcium hydroxide plus NS oil; and Group IV 
had bony defects filled with ready-made bioactive glass materials.  Three weeks later, 50 
percent of the test subjects were euthanized, while the remaining ones remained alive for 
an additional 6 weeks. The outcomes demonstrated that all of the utilized materials were 
biocompatible with the test subjects, yet the bioglass appeared to possess the most 
elevated osteoconductive and osteostimulatory effects among the substances utilized. 
Generally, groups I, II, and III after 3 and 6 weeks exhibited zero signs of bone creation. 
However, after 3 weeks, Group IV showed only small amounts of osteoid tissues, which 
extended to create more fibrous tissues that were seen 6 weeks later. Similarly, the 
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borders of the defects in Group IV had normal thickness, and were smooth and lined by a 
well-defined osteoblastic coating32. An additional research study demonstrated that 
thymoquinone could quicken new bone creation in the fast maxillary extension process; a 
phenomenon which could be of assistance in future orthodontic medication46.  
1.3.3.7: Thymoquinone and oral cancer  
 Cancer stands out as one of the most prevalent diseases in many nations; with the 
global frequency rate expanding yearly47. A cure for this illness is required since the cost 
of its medications is high and the difficulties associated with this malady invariably 
prompt deadly outcomes. Some studies have shown the anticancer impact of 
thymoquinone for a lot of people exhibiting distinctive sorts of malignancies48. The anti-
cancer action of thymoquinone might be accredited to the down regulation of p38β 
MAPK49. Other investigations on human squamous cell carcinoma show that TQ 
prompted cell demise for oral malignancy cells through two different anti-neoplastic 
exercises that can actuate apoptosis and autophagy. Therefore, TQ shows potential in 
being a phytochemical-based, mechanistic, and pathway-targeted cancer prevention 
method50. 
1.3.3.8: Thymoquinone and oral mucositis  
Oral mucositis caused by chemotherapy and radiotherapy represents a difficult 
reaction in tumor medication. An investigation of a rodent model assessed the ability of 
NS to diminish the seriousness of chemotherapy-induced mucositis51. In that research, 25 
male pale skinned rats were partitioned randomly into 3 groups: control, untreated, and 
treated. An intraperitoneal infusion of 5 fluorouracil (5FU) was used to actuate mucositis 
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in rats, and their cheek pockets on the right side were scratched with a wire brush to 
actuate mucositis. Rats in the untreated assembly got oral physiologic saline, and those in  
the untreated category were gavaged every day with 1 mL of NS seed extricate (400 
mg/kg). Rats were sacrificed on day 14, and the cheek pocket territories were excised and 
made ready for histological and immunohistochemical dissection utilizing Bcl2 and 
PCNA safe labelling. Those preparations indicated that when compared with controls and 
5FU untreated rats; NS diminished the histologically observed harm of the cheek mucosa 
in the mucositis model. The results showed NS as a potentially useful prophylactic 
accessory compared to customary chemotherapy for decreasing the seriousness of oral 
mucositis51.  
1.3.3.9: Thymoquinone and oral ulcers  
Oral ulcerations are familiar, frightful lesions that are associated with different 
states, starting with minor trauma to critical systemic conditions, for example, 
hematological, gastroenterological, dermatological, and immunological maladies and 
malignancies52, 53. Topical NS oil was discovered to possess good restorative properties 
on the recuperation of chemically prompted oral ulcers. A trial was conducted on 12 
rabbits used as test subjects. During the trial, researchers injected ulcers with 0.3 mL of 
1% formalin in the cheek mucosa of the rabbits followed by topical application of NS 
twice a day for a period of 3 days. The animals were sacrificed on the fifth day and their 
cheek mucosae were histologically analyzed. The results indicated a noteworthy 
recuperating methodology upgrade for NS medicine and a denoted mitigating movement 
and contrast in the rate of epithelization between NS and control groups. The researchers 
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provided a rationale for those outcomes by attesting that the NS oil accelerated the 
healing of ulcers since it hindered the growth of pathogenic organic entities at the site of   
the ulcers. Moreover, the TQ flavonoids and the other bits in the NS oil (vitamins plus 
minerals) make it a fantastic promoter of ulcer recuperation54.  
1.3.3.10: Thymoquinone antifungal activity  
Oral candidiasis is an ordinary contamination in the oral pit brought on by fungi, 
especially Candida albicans55. Amphotericin B and triazoles, for example, fluconazole 
and itraconazole, are the common antifungal operators utilized systemically or topically 
for contagious infections. Unfortunately, with a prolonged span of therapy, fungal 
resistance develops due to the widespread usage of these drugs. Because of the resistance 
posed by traditional treatments, scientists are now considering alternative medicines as a 
solution56. 
In Hail province, a study57 evaluated the in vitro inhibitory activity of ethanol 
extracts from 6 plants against oral candidal isolates. These samples consisted of 65 
Candida segregates gathered from 175 patients going to private dental centers. The test 
plants, which were bought from nearby Saudi markets, included Zingiber officinale 
(ginger); cinnamene (cinnamon); NS (black cumin); syzygium aromaticum (clove); Piper 
nigrum (black pepper), and chamomile. It was discovered that the most astounding 
inhibitory impacts were arrived at with a 100 μg/mL applications of cinnamomum 
zeylanicum (34. 6 mm) and clove (31. 5 mm), and at the same time, the same 
concentration of black cumin and chamomile recorded the least inhibition zone57. 
However, the mean values of the inhibition zone of both black cumin and chamomile 
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were not fundamentally unique in relation to that of Amphotericin B58. Another study 
asserted by the creators to be the first ever research of its kind, investigated the in vitro 
antifungal characteristics of amphotericin B, ketoconazole, and TQ against candida 
(yeasts and biofilm) in their nanoparticle form in comparison to their traditional 
structures. The effects demonstrated that the nano-sized drugs’ efficiency expanded those 
drug’s capability 24 times against candida albicans for both yeast and biofilms. Thus, 
these results highlight a significant advancement in the therapeutic field, since biofilm 
growth is more retarded and antimicrobial effects are improved59. 
1.3.3.11: Thymoquinone as potent analgesic  
Thymoquinone increases the pain threshold in test diabetic neuropathic treatment 
and lowers experimental neuropathic suffering for spinal cord injury victim60. Early 
research by Abdel-Fattah and coworkers revealed that oral doses of NS oil (50–
400 mg/kg) dose-dependently lessened the nociceptive reactions brought about by intense 
nociceptive jolts for example, by a hot-plate test (thermal stimulus), tail-pinch test 
(mechanical stimulus), and the initial formalin test (chemical stimulus). The researchers 
noted that NS oil and TQ initiate antinociceptive effects via indirect activation of the 
supra spinal µ-1 and κ-opioid, but not the δ-opioid receptor subtypes61.  
1.3.4: Thymoquinone - optimum safe dose: 
Several studies have evaluated the acute and chronic toxic effects of N. sativa seeds 
and its fixed oil, as well as the effects of TQ alone in rats and mice, as given in detail 
below. No toxic effects were reported. For acute toxicity, LD50 values of the plant’s 
fixed oil (oral and intraperitoneal single dose administration to mice) were reported to be 
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26 and 1.9 mg/kg, respectively. In addition, hepatic enzyme levels, including AST, ALT, 
and gamma-glutamyltransferase, as well as histopathological modifications (heart, liver  
kidneys, and pancreas) were not observed in rats treated with N. sativa (oral dose of 2 
ml/kg) after 12 weeks of treatment62. Moreover, the liver enzyme level did not change 
after supplementation with N. sativa up to a dose of 1 g/kg for 28 days, and no toxic 
effects on liver function could be seen63.  
 Clinical usage of thymoquinone is also a safety concern. For example, in the 
experiment the LD50 in mice was 104.7 mg/kg after intra-peritoneal injection and 870.9 
mg/kg after oral ingestion of thymoquinone, while in rats, LD50 was 57.5 mg/kg and 
794.3 mg/kg after intraperitoneal and oral ingestion respectively42. However, 
thymoquinone exhibits anticancer activity in rather small doses, approximately < 10 
mg/kg42, 64. These doses are much greater than therapeutic doses and represent the 
relative safety of N. sativa and TQ, especially following oral administration. In addition, 
no serious side effects were reported in clinical trials65. Furthermore, a wide range of 
standard preparations (seed powder: 2– mg/day-3 g/day, oil: 40– 10 ml/day, and TQ: 1 
mg/day) were used as oral supplementation in different clinical studies, and no side 
effects or toxicity were reported66.  
With this being the current situation, some thymoquinone effects like its analgesic 
nature, anti-inflammatory ability, antibacterial action, and bone formation with Nigella 
sativa (NS) extract and oil have inspired its usage as a pulp treatment agent. As far as 
medical professionals are aware, the possible consequence of this item has not been 
previously tested at the level of human dental pulp cells. Therefore, the objective of this 
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research is to investigate the response of the odontogenic reaction in human dental pulp 
cells in vitro. 
 
 
 
Photo 1: Photos of Nigella sativa and the structure of TQ. 
Note: (a) Nigella sativa seeds (black seeds), (b) Thymoquinone chemical structure, (c) 
Nigella sativa flowers.  
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1.4: Human Dental pulp: 
1.4.1: Dental pulp biology  
Dental pulp is a fine internal fibroblast pulp tissue, which is guarded by three 
mineralized layers: dentin, enamel, and cementum. This mineralized tissue provides a 
mechanical barrier to protect the pulp from pathogens present in the oral environment. At 
the initial stage of a carious attack, the pulp becomes aggravated. With time, the invasion 
progress prompts pulp corruption and infection. Consequently, the infection stretches to 
the underlining and encompassing alveolar bone67. 
 Human dental tissue is derived from the neural crest, thus dental mesenchyme is 
called “ectomesenchyme”. The pulp moves to the oral area and then differentiates into 
cells of the mesenchymal phenotype68. Human dental pulp cells are a varied population of 
cells that contains progenitor/stem cells of odontoblast lineage and react as a mechanical 
support system implanted within a vascular stroma69, 70, 71, 72. The central area of the 
coronal and radicular pulp contains nerve and blood vessels. This region is lined 
peripherally by a specialized odontogenic area, which has four layers. The innermost, the 
pulpal core, is composed of many cells and vascular supply. During the embryonic stage 
neural crest cells give rise to a tremendous number of differentiated cell types including 
neuronal cells, dental mesenchymal cells and osteoblasts 73, 74. At this point the cell rich 
zone contains undifferentiated mesenchymal cells and fibroblasts. It has been reported 
that the human dental mesenchymal cells precipitate approximately 90% of the dental 
pulp cells75. The outsized intercellular space in pulp is composed of type I and type III 
collagen fibrils (56% and 41%, respectively)76. The cell free zone (zone of Weil), which 
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is rich in both nerve networks and capillaries, is located under the outermost 
odontoblastic layer, which lies next to the mature dentin and predentin. Cells found in the 
dental pulp include fibroblasts (the main cell), odontoblasts (dentin forming cells), and 
defense cells e.g. macrophages, granulocytes, mast cells, histiocytes, plasma cells, and 
dentetic cells. The nerve plexus of Raschkow is directed central to the cell-free zone70. 
Besides these cells, endothelial cells, collagen fibrils and also defense cells (lymphocytes, 
microphages), are all found in dental pulp 77. These cells offer nutrition, a receptive 
sensory nervous system 78, 79, and a function in dentinogenesis80. These collections of 
cells usually develop from the neural crest and mesoderm, and afterwards from dental 
follicles. Human dental pulp cells were assumed to be stem cells, which have the 
capability to differentiate into progenitor odontoblast cells, and further differentiate into 
odontoblast cells81. Compared to other stem cells, dental pulp cells are much easier to 
obtain. Several studies indicated that dental pulp cells show multipotency, including 
neurogenic, pancreatic, osteogenic, odontogenic potency82, 83. Dental pulp cells can be 
stored for long duration without losing their multipotency84. Dental pulp cells are 
commonly obtained from extracted third molars and primary teeth, which are usually 
discarded as medical waste. 
1.4.2: Dental Pulp disease  
Dental pulp connective tissue is mechanically protected from different stimuli by 
solid hard tissue such as enamel, dentin and cementum, which maintain its health and 
vitality if the protective layers is intact85. Beside these layers, the dental pulp has defense  
20 
 
mechanisms, which include blocking the dentinal tubules, an inflammatory response, and 
formation of secondary and tertiary dentin, as well as sensory fibers, which provide 
response to different stimuli. Despite this strong protection the pulp can be harmed by 
bacterial invasion or loss it’s vitality86. Pulp irritation occurs due to caries, cavity 
preparation, chemicals, cancer, and trauma. It affects the odontoblast layer or causes 
dental pulp impairment. As a result, the dental pulp component proliferates to the 
affected tissue to supply odontoblasts to create the reparative dentin 87, 88.  
Dental Pulp response to the stimuli could be chronic or undergo necrosis eventually, 
depending on the host defense, the virulence of bacteria, and lymph node drainage89. 
Dentin thickness will also impact the outcome 90. The initial pulp response to caries is 
noticed in the odontoblast layer beneath the lesion, where modifications are seen in the 
morphology of the odontoblast cells as a response to inflammation91. Pulp cannot 
eradicate the damaging bacteria but defense mechanisms including the immune response 
may reduce the ability of the bacterial harm 85. Pulp pathology can be identified as one of 
the following; reversible, irreversible pulpitis, pulp necrosis, hyperplastic pulpitis, 
internal dentin resorption and fibrous degeneration 92. Reversible pulpitis presents mild 
symptoms that diminish when the irritation stimulus is removed and as a result the pulp 
will be able to maintain its vitality. This type of pulpitis may occur after exposure to 
several factors including trauma, caries, attrition and dental erosion. In irreversible 
pulpitis the pulp is severely affected and can not keep its vitality even if the stimulus 
were removed 93. This kind of pulpitis is classified into symptomatic and asymptomatic, 
the symptomatic type occurs when inflammatory edema causes elevation of the intra-
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pulpal pressure, create spontaneous and sharp pain. If the edema is resolved through 
dentinal tubules then asymptomatic irreversible pulpitis occurs which is eventually the 
initial stage of pulpal necrosis. Pulp necrosis may result from any origin of pulp insult 
and with different symptoms 94. 
1.5: Stem cells  
1.5.1 Mesenchymal stem cells:  
These are cells with the capability to self-renew and differentiate into multiple 
lineages. The centrality of these cells in differentiation has led to studies aimed at 
establishing progenitor cell sources as well as the element of tissue regeneration and 
engineering. These cells have also drawn interest in dentistry, with the key objective of 
initiating the regeneration of dental tissue. Such Mesenchymal stem cells (MSCs) 
involved in the regeneration of dentin are from the bone marrow95-97, adipose tissues98, 99, 
umbilical cord blood100 and from dental tissues73. Studies indicate that the first isolated 
dental stem cells were the dental pulp stem cells (DPSCs)87 followed by human 
exfoliated deciduous teeth (SHED) 101, Periodontal ligament stem cells (PDLSC)102 and 
the MSCs from apical papilla of developing teeth (SCAP)103. Some studies have also 
used stem cells from dental follicles hence such cells are called the dental follicle 
precursor cells (DFPCs)104, 105.  
It is also noted that dental tissue-derived MSCs can differentiate into different 
cell-restricted lineages including the osteo-odontogenic lineages when grown in 
appropriate media106-110. The ability of these cells to differentiate into odontogenic 
lineages is of importance in dental tissue engineering. Based on earlier studies, MSCs 
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such as DPSCs, SHED and SCAP can differentiate into the odontogenic lineage in vitro. 
As such, they can regenerate ectopic pulp dentin-like tissue in immunocompromised 
mice21, 35, 38, 45. However, there is some degree of heterogeneity in their phenotypic 
features, a prospect associated with the functional differences of the different dental 
tissue-derived MSCs111. However, the different methods that scientists adopted to study 
dental pulp stem cells makes the entire concept relatively complicated.  
1.5.2: Induced Pluripotent Stem (iPS) cells  
These are stem cells generated synthetically through genetic manipulation of the 
somatic cells112. These cells can be produced from fully differentiated cells that are 
conventionally non-pluripotent cells and can be used to make pluripotent cell lines such 
as embryotic stem (ES) cells113. Since iPSc are biocompatible, they are usable for disease 
modeling, screening of drugs, and to design targeted treatments. The cells are derived 
from the patient’s own cells114, 115 and can then be reprogrammed to an embryonic state 
through retroviral transduction of four major transcription factors112, 113, 116.  
iPS and ES cells have since been shown to be related, since both express stem cell 
genes and proteins, besides having similarities in doubling-time, differentiability and 
potency112, 117. In addition, both cells can proliferate and differentiate into ectoderm, 
endoderm and mesoderm, and are also able to generate mature cells in vitro112, 118, 119. 
These observations on similarity are noted when the iPS are cultured in similar conditions 
to the ES cells. According to Hiyama et al, there are related responses of the odontoblast-
like cells that are derived from the iPS and those from the ES cells120.  
In dentistry, iPS can thus be utilized to reprogram and initiate proliferation of the 
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cells. The iPS with high reprograming competence and proliferation rates are successfully 
isolated from the SCAP, SHED and DPSCs56, 57. They can also be isolated from the bucal 
mucosa fibroblasts, wisdom teeth stem cells121, periodontal ligament fibroblasts and 
gingival and periodontal ligament fibroblasts122. Studies further indicate that iPS cells 
may proliferate and subsequently differentiate into ameloblasts123 in mice models as well 
as odontogenic mesenchymal cells124. The cells can retain odontogenic potentials since 
they retain the memory of their original tissues when cultured in media125, 126. In addition, 
the viral cells that are involved in the transformation of the host cells can be utilized to 
inform transfection, especially when the cells are cultured. 
1.6: Dentin repair  
1.6.1: Odontoblast cells  
Odontoblasts, the cells designed for dentin formation, are detected along the outer 
layer of the pulp chamber as a single cell layer. These columnar cells are elongated, 
terminally differentiated and described as post-mitotic cells. Odontoblasts secrete 
multiple non-collagenous and collagenous proteins to form a special extracellular matrix. 
Among a few other molecules that are synthesized and secreted by odontoblasts are type I 
collagen, dentin sialophosphoprotein (DSPP) and proteoglycans 127.  
Among these molecules, DSPP has been used as a marker for odontoblast 
differentiation and is known as a dentin-specific protein. During tooth development, 
odontoblast precursors leave the neural crest as a part of the ectomesenchymal cell 
population that takes a part in the oral cavity formation 128.   
During tooth formation, the epithelial and dental papillae cells trigger the 
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mesenchymal cells to differentiate into odontoblast cells to form primary dentin129. The 
fully developed functional odontoblasts are polarized with the cell body facing towards 
the pulp tissue and long cytoplasmic processes extending in the predentin and dentin 
layers, where they run through dentinal tubules 130.  
Mature odontoblast cells can’t proliferate after exciting the cell cycle, however the 
pulp tissue is able to differentiate into replacement odontoblasts when mature 
odontoblasts have died 131, 132. They are responsible for forming primary dentin during 
tooth development; secondary dentin after tooth growth and the physiological secondary 
dentin formed after entire root formation. However, Irregular secondary dentin or tertiary 
osteodentin is created in response to various stimuli 133. This tertiary dentin performs as a 
barrier against irritating stimuli to protect the dentin-pulp complex131. Beside their 
function in dentin formation, odontoblasts participate in other crucial roles, including the 
sensory reaction of teeth via mechanosensitive potassium channels134.  
It has also been suggested that odontoblasts may play a role in the immune 
response of the tooth. This hypothesis is supported by findings that odontoblasts 
consistently produce components of innate and adaptive immunity135, 136. Researchers 
have also proposed that odontoblasts can be prompted to express cytokines and 
chemokines135, 137. 
Isolation of odontoblast-like cell lines from either dental papilla or pulp tissue 
can exhibit odontoblast-like characteristics, expression such as dentin sialoprotein (DSP) 
protein suitable for forming small-mineralized nodules138. A cell line which has the 
ability to differentiate into different cell types and produce dentin-like mineralized 
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structures has been described in pulp tissue87, 139.  
In the case of ex vivo transplantation into a mouse, these cells create a layer of 
aligned odontoblast-like cells with their processes related and spreading into the hard 
tissue they have generated. On the other hand, when cultured in vitro these cells do not 
have the exact morphological characteristics of the original odontoblasts. The cell line 
has more odontoblast-like morphology with the typical cellular processes of odontoblasts. 
Interestingly they align into the same orientation when grown on plastic surfaces in vitro. 
These cells also form dentin-like mineralized zones140. 
1.6.2: Dentinogenesis  
Dental pulp: its function as a natural tissue repair by forming reparative dentin.  
During reparative dentinogenesis, the original odontoblasts at the injured site are 
destroyed and exchanged by newly differentiated odontoblast-like cells141, 142. Reparative 
dentinogenesis is initiated by developed tubular fibrodentin matrix. However there is 
molecular signaling involved in cell differentiation. The signaling molecules are 
responsible for the induction of odontoblast differentiation76. During reparative 
dentinogenesis several protein can be detected in the injured site such as bone 
sialoprotein (BSP) and osteopontin (OPN). In addition, odontoblast-like cells were shown 
to express dentin sialoprotein143. There are growth factors expressed as well during 
primary odontogenesis, which play a significant role in the induction of odontoblast-like 
cell differentiation from progenitor pulpal cells such as transforming growth factor beta 
(TGF-beta), direct signaling differentiation, several members of the bone morphogenetic 
protein family and insulin-like growth factor-1 (IGF-1)144, 145. Furthermore, there are 
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multiple proteins demonstrating different phenotypes of odontoblast mineralized matrix 
markers such as Dentin Matrix Protein 1 (DMP1), Dentin phosphoprotein (DPP) and 
Dentin Sialoprotein (DSP), type I collagen and noncollagenous proteins146, 144, 147. 
Differentiation and mineralization of both osteoblasts and odontoblasts require an initial 
period of extracellular matrix biosynthesis as well as proliferation, which is then followed 
by cell differentiation. In the early stages of this process, the extracellular matrix matures, 
and certain proteins associated with the pulp cell phenotype like alkaline phosphatase 
ALP can be revealed76. 
However, dental pulp  (MSCs) display a greater tendency for osteogenic 
differentiation as indicated by the level of expression of odontogenic and osteogenic 
markers such as ALP, runt related transcription factor 2 (RUNX-2), osteopontin and 
osteocalcin 148. 
1.7: Differentiation markers  
1.7.1: Alkaline phosphatase (ALP) 
Alkaline phosphatases (ALP) are grouped into three fundamental types: global 
model, intestinal type, and placental kind149. They are homologous, but non-identical 
genes and are identified by their enzymatic characteristics. Despite universal and 
placental ALPs being properly identified, no detailed examination has been done to 
identify the relationship between ALP and the human dental pulp in detail, however, 
dental pulp ALP showed properties of universal-type ALP (kidney/bone/liver type) 149. 
Basic phosphatase is a film bound catalyst present in most living organisms 150. Alkaline 
phosphatase activity clearly associates with its expression. Its fine regulation is controlled 
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by the actual microenvironment and by the signaling pathways. For this reason, alkaline 
phosphatase activity is regulated mainly by the developmental status of cells. This 
indicates that, alkaline phosphatase expression is a commonly suitable marker of 
differentiation processes both in vivo and in vitro for particular cell types151. It is 
normally found in mineralized-tissue-forming cells152. Thus, a rise in ALP synthesis can 
be an indicator of pulp cell distinction153. Alkaline phosphatase ALP is a sign of 
odontoblast-like identification because odontoblasts show greater amounts of ALPase 
activity than dental pulpal undifferentiated mesenchymal cells154. Likewise, the 
expression of ALP by cultured HDPSCs has been shaped biochemically and utilized as 
an indicator for the cells’ ability to produce mineralized matrix in vitro87, 106 155. ALP in 
the dental pulp is restricted to the odontoblasts and sub-odontoblast surfaces, which 
contain the most elevated amounts of ALP action in the pulp149.  
1.7.2: Dentin sialoprotein (DSP)  
DSP is a protein that is central to the anatomy and structure of dentin. Studies 
suggest that the protein influences mesenchymal differentiation of cells within the pulp. 
According to Li et al., for instance, DSP is the principle component of the extracellular 
matrix of dentin156. Extra cellular matrix (ECM) is made up of both collagenous and non-
collagenous proteins (NCPs)130, 157. Among the components present in non-collagenous 
proteins, dentin sialophosphoprotein (DSPP) is the most plentiful ECM in dentin and is 
converted into three major forms: dentin sialoprotein (DSP), dentin glycoprotein (DGP) 
and dentin phosphoprotein (DPP)158. Among them, DSP and DPP are present in small 
quantities in both odontoblasts and dentin159, 160. Both proteins are important in 
28 
 
dentinogenesis161.  DSP and DPP may function as intracellular transducers. DPP is able 
to induce tooth- and bone-related gene expressions through signaling pathways. DSP 
binds to cell membrane proteins, as a result activation of intracellular protein kinases. 
This may assert their effect in cell proliferation and differentiation along with 
mineralization potential 76, 162.  
In organisms with mutations affecting DSP, dentin genetic diseases are 
observed156. Therefore, the study’s authors conclude that DSP is instrumental for 
mineralization and differentiation of cells in the dentin. Its expression is linked to other 
critical proteins such as the focal adhesion kinase (FAK) and occludin. The findings on 
the importance of DSP in dentin formation are further supported by Wan et al. whose 
study suggests that the differentiation of the dental mesenchymal cells is regulated by 
DSP through novel surface receptors163. 
1.8: Pulp capping  
Vital pulp capping involves covering up an exposed pulp with the objective of 
controlling pulp vitality. Throughout the life of a tooth, vital pulp tissue helps in the 
creation of secondary dentin, peritubular dentin (sclerosis), and reparative dentin as a 
response to biologic and pathologic stimuli. The pulp tissue, with its flow expanding into 
the tubular dentin, keeps the dentin moist, and in turn makes sure that the dentin keeps up 
its resilience and toughness. These attributes make certain that the teeth can successfully 
combat the forces of mastication164. There are three sources of vital pulp vulnerability: 
caries, mechanical origins, and trauma. If pulp exposure happens before caries are totally 
withdrawn, the situation is termed as caries exposure. If pulp exposure happens during 
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the development of a cavity without caries, it is termed as mechanical exposure. 
Mechanical exposures usually happen because of a misadventure during tooth 
preparation. Traumatic pulp exposure may come about due to a sports injury when the 
coronal part of the tooth is damaged165.  
     Every pulp exposure can result in swelling of the pulp and arrested root 
development. Diverse methodologies have been utilized for vital pulp therapy; these 
procedures involve immediate pulp capping and pulpotomy. The principle objective of 
vital pulp therapy is to maintain pulpal tissue, get rid of tissue that is infected with 
bacteria, and encourage repair of the mineralized tissue barrier (dentin bridge) 166.  
  When the vital pulp is exposed, direct pulp capping, pulpotomy or pulpectomy 
can be used to treat it. Direct pulp-capping is a cure for exposed vital pulp including the 
placing of a dental item over the exposed area to help both the creation of a protective 
barrier167, 168, and the preservation of vital pulp 169. Indirect pulp capping is a method 
whereby material is laid down on a thin part of remaining dentin where no vital pulp 
exposure happens. Pulpotomy is different from pulp-capping in that only a portion of the 
remaining pulp is withdrawn before the capping material is inserted165.  
1.8.1 Ideal properties of pulp capping materials: 
A pulp-capping material has to: (1) protect the pulp from thermal shocks; (2) 
insulate from galvanic activity ingrained in all amalgam restorations; (3) prevent the 
spread of mercury from the amalgam restorations into underlying dentin, thus stopping 
color changes of the tooth; (4) possess a pain killing effect on the pulp; (5) have some 
antibacterial action so as to disinfect underlying dentin and residual caries in deep caries 
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lesions; and (6) lower marginal infiltration around restorations, thus stopping the 
dispersal of bacterial toxins and soluble molecules into underlying dentin and pulp170. 
Unfortunately, none of the biomaterials currently present have been able to meet all the 
requirements of an ideal vital pulp therapy (VPT)171.  
In order to guard the pulp from secondary infection generated by residual bacteria or 
microleakage, an ideal pulp-capping agent has to have some antibacterial 
characteristics172. Therefore, since the expansion of dentistry, a number of dental 
materials have been created to gain maximum benefit from them, and generate the most 
helpful tissue response. With a better comprehension of the dentin-pulp complex repair 
and regeneration process, advancements in biomaterials have come up as a way to 
maintain pulp vitality by using minimal invasive dentistry173, 174. With a large variety of 
biomaterials utilized for VPT, it is hard to find the best pulp-capping agent for every 
clinical case. 
1.8.2: Dental pulp Repair materials:  
A great pulp capping methodology is critical because it reclaims the vitality and 
workings of the tooth that might otherwise call for obtrusive dental treatments, for 
example, root canal therapy, or tooth removal175. The first ever recorded pulp-capping 
remedy was performed in 1756 by Pfaff, using a gold foil169. Ever since that first attempt, 
many agents have been suggested for direct pulp capping 176, 177. The objective of the cure 
is to sustain healthy pulp tissue by protecting the pulp from bacterial infection and 
creating a dentin bridge at the exposure area. Prolonged clinical experiments show that 
direct pulp capping can create success rates of between 80% and 90%178, 179 Dentin 
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bridge formation can happen under a myriad of pulp-capping materials such as Zinc 
oxide-eugenol cements, polycarboxylate cements, collagen, calcium hydroxide 
(Ca[OH]2), bonding agents, and glass ionomer cements. More recent components include 
mineral trioxide aggregate (MTA), Biodentine, Emdogain, Propolis, and 
Endosequence180. 
1.8.2.1: Calcium hydroxide   
 Herman was the first physician to use Calcium hydroxide (Ca (OH) 2).  It was 
introduced to the dental profession by Hermann in 1921. Ever since its first application, 
Calcium hydroxide has been regarded as the “gold standard” of direct pulp capping 
material for many years due to its ability to stimulate sclerotic and reparative dentin 
creation, and guard the pulp from thermal stimuli and antibacterial infection 175, 181. 
Calcium hydroxide works as a protective barrier for pulpal tissues. It not only blocks 
patent dentinal tubules but also controls the effects of inorganic acids and their 
leached products from specific cements and filling182. But Calcium hydroxide has some 
patent disadvantages like inflammation and necrosis of the pulp surface after pulp 
capping, high dissolvability in oral fluids, degeneration over time, the creation of tunnel 
defects within the dentin bridge, and low mechanical resistance, which might result in 
future microfiltration and collapse of the medication183, 184.  
1.8.2.2: Mineral Trioxide Aggregate (MTA)  
 Torabinejad made MTA popular for medical use in the early 1900s. A few 
investigations showed that MTA induced less pulpal aggravation and more predictable 
hard tissue barrier creation when compared to hard setting calcium hydroxide 185. Mineral 
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trioxide aggregate (MTA) was the paramount CSM to be advertised. Since its acceptance 
by the Food and Drug Administration in 1998, it has been utilized with rising frequency, 
with very good clinical and in vitro outcomes186. MTA has a greater success rate, leads to 
less pulpal swelling and a better formation of a hard dentin bridge than Calcium 
hydroxide 187. However, MTA has some demerits; it takes a while to set, it is hard to 
handle, and continuous usage causes the teeth to lose color with time188, 189.  Additionally, 
MTA may result in weakening of dentin by creating a high pH environment190, and other 
disadvantages such as high cost have been witnessed191. MTA is mostly used in immature 
teeth with open apices instead of permanent teeth; probably because reparative dentin 
does not occur in aged pulp cells compared to young pulp cells192, 193. Therefore, MTA is 
used with biologically active molecules like direct pulp capping agents that can potently 
prompt and expedite reparative dentin formation in vivo. There are two types of MTA: 
White and Gray MTA. The major dissimilarity between GMTA and WMTA is the 
existence of the higher levels of aluminum, magnesium, and iron in the GMTA. Because 
of the expected discoloration effect of gray MTA, white MTA is preferred in endodontic 
treatment. No major difference has been observed between GMTA and WMTA in terms 
of calcified bridge thickness and pulp inflammatory reaction to the capping items 194. 
1.8.2.3: Propolis (Russian penicillin)  
Propolis has been called ‘bee glue’. Its name is derived from the Greek word pro, 
meaning defense 195, 196. It is a product of bees and is a natural, sticky gum made as bees 
collected pollen from different plants with salivary enzymes and metabolic products 
added 197. It has a diversity of colours, from yellow, reddish, brown, and green, with a 
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unique aroma. Propolis is gathered from trees and shrubs by bees. The principle 
concoction classes found in Propolis are flavonoids, phenolics, and different fragrant 
mixes. Flavonoids are famous plant compounds, which possess antioxidant, antibacterial, 
antifungal, antiviral, and anti-inflammatory characteristics198.  It has flavonoids, 
phenolics, iron, zinc and other numerous aromatic components199. Parolia A et al. 
collated propolis, MTA and Dycal histologically in human dental pulp and found out that 
Propolis and MTA exhibited comparable bridge formation to Dycal198. Propolis has been 
proven to exhibit antioxidant, anti proliferative, antibiotic activities and anti-
inflammatory properties. The antitumor mechanisms of propolis have been indicated to 
be via the generation of apoptosis as well as by inhibiting telomerase expression. Gunduz 
et al. demonstrated that propolis decreased the number of malignant cells significantly 
compared to the control group without propolis200. 
1.8.2.4: Zinc oxide Eugenol cement  
ZOE cements have been utilized in dentistry for a number of years as bases, 
liners, cements, and temporary restorative items. Its usage for direct pulp capping is 
contentious since Eugenol is very cytotoxic201. It is a fact that ZOE frees up eugenol in 
amounts, which are cytotoxic202, 203. ZOE also has high interfacial leakage and although 
this leakage is not important, ZOE can create a biologic seal due to the Eugenol release 
which can affect its effectiveness204. One human study found out that utilizing ZOE as a 
direct pulp-capping agent results chronic swelling without pulp healing and without 
dentin bridge formation for up to 12 weeks post-operatively205. 
1.8.2.5: Poly Carboxylate cement  
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G. McWalter et al. found that it does not have an antibacterial effect and does not 
result in calcific bridge formation206. 
1.8.2.6: Calcium phosphate cement (Cpc)  
Calcium phosphate is another pulp capping agent, which was initially utilized in the 
1900’s. Its merit is that it assists in shaping a dentin bridge without any tissue corruption. 
It possesses great physical properties. Likewise, a lack of pulp swelling is seen compared 
to calcium hydroxide. The discharge of calcium ions may be the main reason for its 
successful pulp capping property, due to the action of calcium on differentiation, 
proliferation, and mineralization of pulp cells. But calcium phosphate never used to be 
popular in dental therapy due to a lack of evidence in its effectiveness 182. The outcome 
of a research done by HM Chaung revealed that calcium phosphate cement and pure 
calcium hydroxide items resulted in similar responses with regard to their 
biocompatibility and induction of hard tissue barrier creation. A much older, hard tissue 
blockage with a higher level of mineralization and creation of dentinal tubules was 
witnessed after 24-weeks. Calcium phosphate cement tends to be at a much higher level 
than pure calcium hydroxide and may have a place in clinical application, although many 
issues have to be further investigated207.  
1.8.2.7: Glass Ionmoer /Resin modified glass ionomer  
Glass ionomer gives a phenomenal bacterial seal and offers useful 
biocompatibility when applied close to but not in direct contact with the pulp. RMGIC as 
a direct pulp capping material exhibited chronic inflammation and did not lead to 
formation of a dentin bridge; while the calcium hydroxide control groups indicated 
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essentially better pulpal healing208,202, 209. (GI) and (RMGI) although not as cytotoxic as 
ZOE, GI/RMGI is cytotoxic when in direct cell contact. The traditional formulations are 
less toxic than the resin-modified formulations210, 211,212,213. But this fact should not be 
interpreted as a caveat against the use of GI/RMGI in deep cavities. Because of glass 
ionomer’s capacity to chemically bond to tooth structure, it can stop the diffusion of 
potentially toxic items from dentin to the pulp.  
    One experiment on direct pulp capping using glass ionomer in this case, RMGI – 
showed chronic inflammation and absence of dentin bridge formation up to 300 days 
post-pulp capping, whereas, the calcium hydroxide control groups exhibited remarkably 
higher levels of pulpal healing214. 
1.8.2.8: MTYA1Ca  
Atsuko Niinuma came up with resinous direct pulp capping agent holding calcium 
hydroxide. The powder was made up of 89.0% microfiller, 10.0% calcium hydroxide, 
and 1.0% benzoyl peroxide, and was blended with 67.5% triethyleneglycol 
dimethacrylate, 30.0% glyceryl methacrylate, 1.0% o-methacryloyl tyrosine amide, 1.0% 
dimethylaminoethylmethacrylate and 0.5% camphorquinone). MTYA1-Ca led to dentin 
bridge formation without creation of a necrotic layer and was not lower in position to 
Dycal histopathologically. Therefore, it has been found that the newly developed 
material, MTYA1-Ca, has the ability to be a good direct pulp capping material215. 
1.8.2.9:Emdogain (EMD) 
EMD stands for enamel matrix derivative discharged from Hertwig’s epithelial 
root sheath and happens during porcine tooth development. It may be the ultimate 
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controller of enamel mineralization and assumes a paramount part in periodontal tissue 
structuring. It fortifies the recovery of acellular cementum, periodontal ligaments, and 
alveolar bone. 
EMD has bone morphogenetic proteins (BMP)-like molecules and BMP 
expressing cells. BMP-like molecules in EMD encourage odontoblast disparity and 
reparative dentin creation. Of late, it has been revealed that EMD limits inflammatory 
cytokine fabrication by immunocytes and has TGF-β-like molecules. It can form a proper 
environment for encouraging wound healing in damaged pulp tissues 216. Y. Nakamura et 
al. revealed that the quantity of hard tissue created in EMD treated teeth was more than 
two times that of the calcium hydroxide in treated control teeth217. K. Al-Hezaimi 
investigated Calcium hydroxide, ProRoot White MTA and white Portland cement after 
EMD application on the bare pulp. MTA resulted in a better quality reparative hard tissue 
reaction with the adjunctive use of EMD compared to calcium hydroxide218. 
1.8.2.10: Odontogenic Ameloblast Associated Protein (ODAM) 
ODAM is expressed in ameloblasts, odontoblasts, and pulpal cells. ODAM takes part 
in ameloblast maturation and enamel mineralization. I. S.Yang et al. noted that ODAM 
increases reactionary dentin formation near the pulp exposure site and preserves regular 
odontoblasts in the leftover pulp 219. Odontogenic ameloblast-associated protein (ODAM) 
especially expresses ameloblasts and odontoblasts and plays a part in the mineralization 
of the enamel. Odontogenic ameloblast-associated protein (ODAM) is part of the 
secretory calcium-binding phosphoprotein family, which is important to 
biomineralization in vertebrates. In mammals, ODAM is expressed by ameloblasts in the 
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maturation stage; when enamel that is not fully-grown turns into a hypermineralized 
inorganic tissue. According to In-Seok Yang, the recombinant Odontogenic Ameloblast 
Associated Protein (ODAM) group exhibited decreased inflammatory response compared 
to the White MTA groups. Limited reaction of odontoblasts led to normal pulp tissue 
appearance without too much tertiary dentin formation and extermination of the pulp 
cavity. ODAM increases reactionary dentin formation near the pulp-exposed site and 
preserves normal odontoblasts in the remaining pulp219. 
1.8.2.11: Astor oil Bean (COB) Cement: 
COB is made up of 81-96% triglyceride of ricinoleic acid, and is regarded as a natural 
polyol with three hydroxyl radicals. COB or RCP (Ricinus Communis Polyurethane) was 
first created as a biomaterial for bone repair and healing after local bone destruction. Due 
to these positive attributes, the element is an excellent alternative for use in pulp capping 
220.  
Castor oil bean cement (COB) is a foreign material utilized as an endodontic sealer, 
and is an alternative substance for direct pulp capping. According to an experiment by S. 
E. Camargo, there were more inflammatory cells observed in the calcium hydroxide 
group than in the castor oil bean group after 50 days of observation. These results show 
that the COB cement results in less inflammatory response for long periods221.  
1.8.2.12:Theracel  
TheraCal LC is a light cured, resin customized calcium silicate filled liner made for 
use in direct and indirect pulp capping, as a cautionary base/liner under composites, 
amalgams, cements, and other base substances. TheraCal LC acts as a barricade, which 
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guards the dental pulpal complex. The proprietary ingredients in TheraCal LC are 
tricalcium silicate particles in a hydrophilic monomer that results in a significant calcium 
release transforming it into a distinctively stable and durable material for a liner or base. 
Calcium release promotes hydroxy apatite and secondary dentin bridge creation. 
TheraCal LC may be set directly on pulpal openings after hemostasis is obtained. It is 
used for any pulpal wounds, including carious exposures, mechanical exposures or 
exposures due to trauma. The ability of TheraCal to be cured to a depth of 1.7 mm may 
avoid the risk of untimely dissolution. These characteristics offer major merits in direct 
pulp capping medications222.  
1.9: Rationale and clinical significance for this research 
Due to challenges exhibited by currently used pulp capping materials, researchers 
have turned to natural remedies. Thymoquinone is a major bioactive component of 
Nigella sativa, a plant used in traditional medicine to treat a variety of symptoms. Some 
of the observed properties of thymoquinone are that it is analgesic, antibacterial, is an 
anti-inflammatory, an antioxidant and induces osteogenesis.  
Many studies have shown that the compositions of dentin and bone tissues are 
relatively similar. Studies have also indicated that certain molecules such as DSP that 
were originally considered to be specific to dentine are present in alveolar bone223, 224. 
Therefore, the close anatomical resemblance between odontoblasts and osteoblasts 
suggests that they may exhibit similarities in biochemical responses to chemicals and 
treatments. 
 Structurally, bone and dentine exhibit several common features, with both 
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odontoblasts and osteoblasts having similar mesodermal embryonic origin. The 
commonality of their origin explains some of the similarities found in their formation and 
structures. Recent studies have also shown similarities in the morphologies of dentinal 
tubules and osteocyte canuliculi155. In addition, recent molecular research results 
demonstrate striking similarities in the behavior of odontoblasts and bone cells at 
different stages of their life cycles223.  
A few studies showed the osteogenic effect of TQ on bone and pulp cells. For 
example, Thymoquinone has the proven ability to accelerate the proliferation and 
differentiation of osteoblasts225.  
In addition, for the first time a recent preliminary study showed the inductive 
potential of Nigella sativa oil for osteogenic differentiation in dental pulp mesenchymal 
stem cells. Authors suggest that the Nigella sativa oil can be used safely as an alternative 
clinical nutrition or as a mouthwash after dental treatments226.  
Furthermore, there is one animal study evaluates the odontogenic effects of TQ as a 
pulp capping material. The study showed promising results on testing TQ when used as a 
capping medicament in pediatric dentistry to replace Formocresol due to its reported side 
effects. The study contrasted the histopathological pulp reaction of N.S oil and 
formocresol (FC) in canines. The results revealed that the Nigella sativa extract showed 
mild to moderate vasodilatory effects, with just a few inflamed cells and a continuous 
odontoblastic layer. In contrast, FC specimens exhibited advanced swelling with extreme 
vasodilatation, inflammatory cell infiltration and degeneration. Thus, using Nigella sativa 
retained the vivacity of the pulp, which makes it a good pulpotomy material in clinical 
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practice7. The fact that thymoquinone forms a continuous odontoblastic layer in the 
above study and that it has a promising effect on bone as well as its therapeutic properties 
make it a promising candidate for pulp capping. 
Moreover, there are significant similarities between odontoblasts and osteoblasts 
leading to suggestions that the TQ could have similar biochemical effects in both cell 
types. Based on the premise of potential similarities in biochemical activities of TQ in 
odontoblasts and osteoblasts, this study was designed to evaluate the odontogenic effect 
of TQ on human dental pulp cells. 
The present study also evaluated thymoquinone on human dental pulp cells 
without isolating the stem cells, since the mesenchymal progenitor cells may have a 
potential role in dentin regeneration, based on literature findings.  Following these criteria 
may encourage the regeneration of dentin in vivo hence making the current study 
clinically relevant 227.  
During dentin formation, odontoblasts synthesize and secrete several non-
collagenous proteins into the dentin extracellular matrix 228. Of these, dentin sialoprotein 
(DSP) and alkaline phosphatase (ALP) are considered to play a regulatory role in the 
mineralization of reparative dentin and are therefore considered as specific markers for 
the odontoblast phenotype228.  
Thus, our objective in this study was to investigate the effect of different 
concentrations of thymoquinone on human dental pulp cell attachment, proliferation and 
differentiation by assessing ALP and DSP as specific markers for the odontoblast, and to 
determine the optimal concentration of thymoquinone for potential use in pulp capping. 
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1.10: Hypothesis  
It is hypothesized that Thymoquinone enhances the odontogenic activity of normal 
human dental pulp cells by enhancing cell attachment, cell proliferation and cell 
differentiation of normal human dental pulp cells. 
 
The null hypothesis (H0) is that there is no difference in cell attachment, proliferation 
and odontogenic differentiation between the experimental sample groups of 
thymoquinone treated cells and the control group of untreated human dental pulp cells. 
 
1.11:Objectives 
 
Objective 1: To measure cell attachment efficiency of human dental pulp cells at 16 
hours on human dental pulp cells treated with thymoquinone concentrations, 5 μM, 10 
μM, 15 μM, 30 μM and 0 μM as control in standard tissue culture plates. 
 
Objective 2: To measure cell proliferation rates at two different time intervals (7 and 21 
days) on human dental pulp cells treated with thymoquinone concentrations 5 μM, 10 
μM, 15 μM, 30 μM and 0 μM as control in standard tissue culture plates. 
 
Objective 3: To measure the odontogenic activity and differentiation potential at two 
different time intervals (7 and 21 days) on human dental pulp cells treated with 
thymoquinone concentrations 5 μM, 10 μM, 15 μM, 30 μM and 0 μM as control in 
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standard tissue culture plates. 
This was achieved by: 
a)  Measuring the alkaline phosphatase (ALP) activity in the collected supernatants from 
cell cultures at 7 and 21 days. 
b)  Measuring the dentin sialoprotein (DSP) levels expressed in the collected supernatants 
from cell cultures at 7 and 21 days. 
 
1.12: Approvals and training  
This study was approved by the Institutional Biosafety Committee at Boston 
University (IBC approval 13-046). All necessary human subject trainings were 
completed through the Collaborative Institutional Training Initiative (CITI), as well as 
online trainings provided through the Office of Research at Boston University. Exempt 
review (IRB# H-33173) from the human subjects was granted from the Institutional 
Review Board to use biological waste material of human extracted teeth.  
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Chapter Two: Material and methods 
2.1: Materials 
All materials, chemicals and equipment were listed in the following tables: 
 2.1.1: List of used materials (Table 1) 
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 2.1.2: List of chemicals, enzymes, growth media and assay kits (Table 2) 
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 2.1.3: List of equipment used(Table 3) 
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2.2: Methods: 
2.2.1: Agents  
2.2.1.1: Thymoquinone preparation and properties  
Thymoquinone media was prepared following directions from Dr. A. Shaker, 
(pharmacist in King Abdulaziz University, Jeddah, KSA). TQ stock was prepared in 
DMSO so that the final DMSO concentration on cells was less than 0.5%. The golden 
flaky TQ crystals (photo 2) were slightly ground in a mortar and loaded onto a sheet of 
weight paper, which had been previously placed on the pan of the mass balance so that 
the balance could be set to zero. The balance door was then opened and the powder was 
transferred to a container with 50 mL DMSO solvent. Different TQ concentrations were 
then prepared in 50 mL DMSO as shown in (table 4).  
Thymoquinone weight calculation in 50 mL DMSO was performed based on the 
thymoquinone molar mass of 164.20 g/mol229. Thymoquinone has certain characteristics 
that had to be considered in this study. Firstly, it is unstable in aqueous solution and is 
light sensitive. As such, TQ was dissolved in DMSO and stored in the dark26. Each 
prepared TQ concentration was covered with aluminum foil and placed over the vortex 
mixer for 1 hour. Each concentration was subsequently filtered under sterile condition in 
the biological hood (Photo 3). Five TQ stocks were prepared with different 
concentrations, 5 mM, 10 mM, 15 mM, and 30 mM. The preparations were labeled and  
stored separately at room temperature for up to 2 months (table 5).  
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Photo 2: Thymoquinone crystals. 
 
Note: This photograph was taken of the thymoquinone crystals before grinding. 
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Photo 3: Filtration of TQ particles 
 
Note: The photograph was taken while filtering thymoquinone particles with the solvent. 
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Calculations for solution preparation:  
 
 Thymoquinone (164.20 g/mol): a 1M solution requires 164.20 g in 1L 
 1M=1000mM; 100mM=0.1 mol/L= 16.4 g in 1000mL  
 
Table 4: Preparation of different TQ concentration stock solutions. 
 
Note: Thymoquinone stock was prepared for each condition, 5 mM, 10 mM, 15 mM, and 
30 mM.  
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Table 5: Preparation of TQ end concentrations. 
 
 Note: This table presents thymoquinone solution preparation for each condition with 
end concentration, 5 μM, 10 μM, 15 μM, and 30 μM, in 30 mL prepared growth media. 
 
2.2.1.2: Solvent Dimethyl Sulfoxide (DMSO) solvent preparation  
Dimethylsulfoxide (DMSO) was utilized as the solvent for the TQ grained 
particles and the final DMSO concentration on cells was less than 0.5%225. In this study, 
the solvent concentration that was used was 0.1% (v/v). DMSO is widely used in cell 
culture for its physical properties and low toxicity. In addition, it prevents the formation 
of ice crystals during the freezing process thus preventing possible destruction of cells. 
DMSO is highly hygroscopic and light sensitive and should be kept in dark amber 
colored containers.   
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2.2.1.3: Growth media preparation  
The growth media was added to the explant culture (8mL), secondary passage 
(80mL) and in each well (1mL) before cell seeding (Table11).  
Standard 24-well plates for the attachment and proliferation experiments were 
used for the time intervals, 16 h, 7 and 21 days. However, for the differentiation 
experiments, the media were replaced at day 3 with odontogenic media. Growth media, 
500mL total volume, contained 444.5mL Eagle’s Basal Medium (1xBME), 50mL 
supplements of 10% fetal bovine serum, 5mL of 1X Penicillin/Streptomycin antibiotic 
(200,000 U/L), and 0.5mL 1X Fungizone (3mg/L) to prevent microbial contamination 
and facilitate cell adhesion. For cell attachment and cell proliferation experiments, the 
media was prepared by adding 30 μL from each TQ stock solution to 30mL growth media 
to make end concentrations of thymoquinone of 5 μM, 10 μM, 15 μM, and 30 μM. 
Another growth media was prepared in 30 mL for each vehicle. This was done by adding 
30μL DMSO in 30 mL as a vehicle for TQ and 300 μL Ethanol in 30 mL as vehicle for 
the vitamin D3 in odontogenic media (table 6). 
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Table 6: Preparation of the growth media. 
 Note: Growth media was prepared to achieve 500mL total volume. 
 
2.2.1.4: Odontogenic media preparation:  
Odontogenic media was added to the cell culture in days 4 and 18 without vitamin 
D3 supplement. It consisted of 10% charcoal stripped FBS, Penicillin/streptomycin 
antibiotic 1:100 (v/v), Menadione (vitamin K) of 10-8 M, β-Glycerophosphate (216 
g/mol) with end concentration 10 mM, 1.5 mg/mL L-ascorbic acid, L-glutamine of 2 
mM, and 300 µL of Vitamin D3) (172g/mol) giving an end concentration of 10nM, all in 
a calculated volume of BME plain media. Four lab tubes were prepared for different TQ 
concentrations 5 μM, 10 μM, 15 μM, and 30 μM. Another two tubes were prepared 
separately by having 30mL odontogenic media with each having 30μL (stock) DMSO for 
TQ and 300μL (stock) Ethanol vehicle for vitamin D3. The last tube had only 
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odontogenic media for the control group. 300μL Vitamin D3 was added to all tubes, with 
concurrent addition of the odontogenic media in day 5 and 19 (table 7). 
 
Table 7: Preparation of odontogenic media in total volume 30mL. 
 
Note: Odontogenic media for day 4 and 18 was prepared without vitamin D3 and the 
same media for day 5 and 19 was prepared with vitamin D3.  
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2.2.1.5: Crystal Violet dye preparation: 
Crystal violet dye is histological staining material known as “methyl violet” and 
used in Gram’s method of classifying bacteria. It has antibacterial and antifungal 
properties, and has been used as an antiseptic as well.  The name crystal violet refers to 
the color since it is not made from either violets or gentians. It is used to determine 
attachment of cells to various surfaces. It yields quantitative data that gives information 
about the relative density of cells adhering to multiple cell surfaces.  The dye in this assay 
works by staining the cell’s DNA. Upon solubilization the amount of dye taken up by the 
monolayer can be quantified by the use of a spectrophotometers plate reader. The 
maximum absorption spectrum for Crystal Violet is 590 nm. The dye is prepared by 
dissolving at a concentration of 0.2% (w/v), with deionized water as the solvent. The 
materials needed for the preparation include; 10% neutral buffered formalin, 0.2% crystal 
violet dye solution, 1xPBS, deionized water, pipettes and a plate reader. The protocol 
followed to prepare crystal violet is as follows: 
1. Aspirate the growth or odontogenic media from each well, add 1mL warm 1X PBS to 
wash the plate gently. Then carefully aspirate the PBS away from the cells. 
2. Fix the cells by adding 0.5mL 10% neutral buffered formalin then incubate for 1 hour at 
RT or overnight at 4°C until the plate is ready for use. 
3. Rinse the wells with deionized water at least twice. Then stain with 0.5 mL 0.2% crystal 
violet solution for 60 minutes at RT. 
4. Aspirate the crystal violet solution from each well, and then wash with deionized water 
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several times until blue stain disappears. The cells will be stained blue and fixed at the 
well’s base. 
5. Use the plate reader with absorbance 590 nm wavelength to detect optical density of cell-
bound crystal violet. Empty wells are used as background control group for a reading 
reference. 
2.2.2: Experiments prepration: 
 2.2.2.1: Patient Selection and Isolation of odontogenesis progenitor cells from human 
dental pulp  
Human dental pulp explants were obtained from fresh extracted 3rd molars of 
three random healthy female patients with an age range of 25-35 years old. The 
participants were screened to ensure that they had no systemic and metabolic bone 
diseases or acute infections, and that they had not used steroids in the 6 months preceding 
the surgery. Individuals who met the inclusion criteria subsequently gave their informed 
consent before the extraction procedure at Boston University School of Dental Medicine's 
Oral Surgery Clinic. Pulp tissues were obtained from the surgically extracted teeth. 
Exclusion criteria included any restorations, carious lesions, non-vital teeth, trauma, and 
endodontic lesions, or any other conditions affecting tooth integrity and formation. 
Human dental pulp cells were obtained using a previously published protocol with some 
modification230. 
Immediately after extraction, the fresh teeth samples were collected and stored in 
a sterile tube containing 1X phosphate buffered saline (PBS) solution. They were then 
transported to our lab in an icebox container, which held them prior to processing within 
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one hour. A sagittal indentation was made with a high-speed hand piece and 330 bur 
using copious water spray without entering the pulp chamber. Teeth were sectioned with 
a #7 chandler bi-bevel bone chisel (Hu-Friedy) and pulp tissue was extracted using sterile 
cotton pliers. The pulp tissue was gently removed from the teeth, cut into small pieces 
using a scalpel blade, pulp was cut into 4 pieces with using sterile micro dissecting 
scissor and #11 surgical blade into 2-5 mm long pieces then placed in petri dish 
containing sterile PBS. The rest of the isolation procedure and maintenance were 
performed entirely under the class II biological lab safety hood to ensure sterile 
conditions. The pulp pieces were detached with sterile instruments and immediately 
placed in 12.5cm2 flasks containing 8mL culture media, which cover all the pulp 
fragments. All mentioned tissues were maintained at 37°C, in a standard CO2 incubator 
with 5% carbon dioxide, and saturated humidity (photo 4).  
 
Primary cell culture: 
Primary cell culture in the 12.5mL flask with growth media was allowed for 3-4 
weeks until cells reached about 70-80% confluence (photo 5) after which they were 
transferred to a larger 225 cm2 tissue culture flask with 80 mL growth media, and allowed 
to grow for 2 weeks to reach 70-80% confluence (photo 6). Growth media was changed 
every day for a total of 7 days, followed by changing it every 72 hours thereafter. The 
process of media change was as follows; first the old media was aspirated, then 10 mL of 
1X PBS was added to rinse the inner surfaces of the flask then aspirated immediately 
before 8 mL of new growth media was quickly added. Pulp pieces were kept in the flask 
58 
 
for the first 7-10 days to allow cell migration from the pulp tissue and attachment to the 
flask surface. After that time, remaining pulp tissue pieces were aspirated and discarded 
to allow the attached cells to grow freely on the flask surface and reduce the risk of 
microbial contamination. 
 
Photo 4:  Steps of HDPCs extraction.  
Note: The picture presents the process of extracting HDPCs from the extracted teeth and 
the subsequent culture of the cells in appropriate media.  
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Photo 5: Display of primary cell culture in 12.5 cm2 flask.  
Note: Cells proliferated all around the pulp piece to reach 70% confluence in 3-4 weeks. 
Media was changed daily every day in the first week then every 3 days.   
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Photo 6: Secondary cell culture in 225 cm2 . 
 
Note: Secondary cell passage was obtained after 10-14 days. Media was changed every 3 
days after 7 days.  
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2.2.2.2: Tissue culture maintenance and expansion  
When cells reached an approximately 70-80% confluence after 3-4 weeks, media 
was aspirated, and the cells were washed with 1X PBS which was then aspirated. 1 mL of 
0.05% Trypsin- EDTA was added the flask was returned to the incubator for 3-5 minutes 
at 37°C. The attached cells in the flask were trypsinized, causing them to detach, in order 
to transfer them to a 225 cm2 flask for the secondary passage cell culture according to the 
experiment design (Photo 6). After checking for cell detachment from the flask surface 
using the light microscope, the reaction of the trypsin was blocked by adding 10mL of 
media to the flask (photo 24, 25). Cells re-suspended in the media were then aspirated 
and collected in a sterile 15mL disposable tube for 1000 rpm centrifugation for 5 minutes 
at RT. 
A pellet of cells in the bottom of the tube was evident after centrifugation (see 
photo 7). The solution above the pellet containing the trypsin was carefully aspirated and 
replaced with fresh media. After re-suspension in the tube, the media with cells was then 
transferred by pipette to be cultured in the 225 cm2 flask with 80mL of growth media. 
This secondary cell culture took about 2-3 weeks to reach 70-80% confluence. The total 
volume of growth media required for the big flask is 80 mL and plates were washed with 
30 mL sterile PBS whenever new media was added. When cells in the 225cm2 flask 
reached confluence, they were trypsinized again with 3mL of 0.05% Trypsin EDTA.  
Then the reaction was blocked with 27mL of the growth media. The cells were 
subsequently counted using a hemocytometer (Reichert-Jung) under a microscope as 
described by Freshney 231. Cells were counted by adding 40μL of the suspended cells to 
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the edge of the hemocytometer chamber to allow the suspended cells to run out of pipette 
and drawn under the cover slip via capillary action (photo 8). A light microscope with 
20x magnification was used to focus on the grid lines in the chamber, cells were counted 
in the largest area bounded by 3 parallel lines, which is one square millimeter. Cells from 
each square were counted, divided by 4 and the result was multiplied by 104. Cells 
numbers were different from one patient to another according to the donor’s age (Table 
10). Suspended 3x103 cells per mL were transferred to 24 well plates and grown to 
confluence with various concentrations of TQ supplement media. At 16 hours, cell 
attachment and proliferation analyses were conducted. At 7 and 21 days, cell proliferation 
tests were also conducted in 24-wells culture plates (photo 9,11). The rest of the plates 
were for the differentiation markers alkaline phosphatase and dentin sialoprotein 
experiments (photo 10, 12). Table 11 summarizes the volumes that were used in the 
various steps for the expansion experiment.  
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Photo 7: Pellet of cells after centrifugation.  
Note: A pellet of cells in the bottom of the tube was evident after centrifugation. Yield 
size varied from patient to patient.  
.   
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       Photo 8: Hemocytometer  
       Note: A hemocytometer was used to count cells under the light microscope. 
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Photo 9: Experimental design 
Note: This is a summary of the experimental design used in the study.   
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Photo 10: The experiments design used, including the time points. 
Note: D.M: stands for Differentiation Media and O.D: for Optical Density.  
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Photo 11: Conditions in a 24 well plate with cells.  
Note: Presented is the labeling of a 24-well plate at time points16 hours, 7 days and 21 
days in attachment and proliferation study. 
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Photo 12: Experimental plates in the biosafety hood.  
Note: All the 24-wells plates with the growth media incubated on the first day with different 
conditions.  
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2.2.2.3: Determination of the optimal cell density with different seeding concentration by 
7th day  
A pilot study was done to determine the optimal seeding concentration for our 
experiment in order to reach cell confluence at 7 days. This was essential to ensure that 
during that time, no cell death occurs, which would undermine the experimental 
outcome. The standard concentration was obtained by testing various seeding cell 
concentrations on 24 well culture plates (Table 8). The concentrations that were tested 
were 0.7x103, 1x105, 1.5x104, 3x103, and 4x105 per mL. Densities of the cells were 
closely monitored daily by using a light microscope and recorded according to (photo 
13). It was then determined that the optimal seeding concentration is 3x103 cells to reach 
70% confluence by day 7 (Table 8) and (Figure 2). 
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Table 8: Selected seeding numbers and their confluence. 
Note: Seeding numbers and their confluence is presented in percentage for one week. 
Seeding number 3x103 presented 70% confluence by day 7 by visual estimation. Hence 
it was considered the optimal cell concentration.  
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  Photo 13: Percentage confluence by day 7. 
Note: The cell confluence by visual estimation for the seeding number in the 7th day. 
Confluence percentage refers to the coverage of the well or the flask by the cells.  
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Figure 2: Tracing confluence by day 7. 
Note: The confluence at 7 days has different initial cell seeding densities, 0.7x103, 1x105, 
1.5x104, 3x103, and 4x105 per mL. Confluence was 70% by day 7 with the seeding 
number 3x103, which was determined to be the optimal cell seeding density for this 
study. 
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2.2.2.4: Determination of the thymoquinone solvent’s toxicity by cells number and 
morphology  
A pilot study was done to test the appropriate solvent of TQ for HDPCs. Solvent 
toxicity was determined by observing cell morphology under the light microscope and 
counting the cell numbers after 24 hours. Dimethylsulfoxide (DMSO) and Propylene 
glycol (PG) solvents were tested for use in this study. Five working lab tubes were 
prepared for the TQ solvents. Each of the solvents was evaluated with different 
concentrations: 0.05%, 0.1%, 0.2%, 0.4%, and 1.0%, and the control group without the 
solvent (photo 14). Cells were seeded to number 3X103 in 24 wells plates, each having 
2.5mL tissue culture media. HDPCs were seeded on various solvent concentrations. Cells 
were incubated for 24 hours and maintained in a humidified atmosphere at 37 °C with 5% 
CO2.  
The next day, the cell morphology was observed under the light microscope. It 
determined that cell death and cell clusters occurred with high concentrations of both 
solvents. DMSO with concentration 0.1% presented healthy attached cells with good 
expansion. On the other hand, PG revealed abnormal morphology of the pulp cells, and 
cell death was detected under the microscope. This demonstrates severe toxicity, 
especially with higher solvent concentrations. On the next day, the cells were trypsinized 
then counted, and numbers were recorded using the hemocytometer under a light 
microscope (table 9). The results from cell counting indicated less cell numbers with 
higher solvent concentrations (figure 3). For example, the 0.4% concentration of PG 
solvent group showed severe cells death in comparison with the 0.2% PG group (photo 
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15). However, 1% concentration of DMSO solvent groups showed less cell growth 
compared to the 0.1% concentration DMSO group, which showed better expansion and 
attachment (photo 16). Furthermore, 0.1% concentration groups showed similar cell 
numbers to the control group. This pilot study showed the highest cell growth with 
DMSO when the concentration was between 0.05-0.1%.  
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Photo 14: Plate templates of varying DMSO and PG concentrations.   
Note: This is a 24 well plate template of various concentrations from Dimethylsulfoxide 
(DMSO) and Propylene glycol (PG).  The solvents were analyzed and the results were 
noted.  
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Table 9: Cell numbers with varying DMSO and PG concentrations  
Note: Cell numbers with DMSO and PG in different concentrations were counted to 
determine the proper solvent and its optimal concentration %. 
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Figure 3: Comparison of toxicity of solvents DMSO and PG on human dental pulp cells.  
Note: Cell toxicity was evaluated by cell numbers in Dimethylsulfoxide (DMSO) and 
Propyleenglycol (PG) with different solvent concentrations in 24 hours. 
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Photo 15: Effects of different PG concentrations on cell morphology. 
Note: The image shows cell morphology under a light microscope with different PG 
concentrations. Cell death was reflected by cell behavior using Propylene glycol (PG) in 
different concentrations. 
 
. 
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Photo 16: Effects of varying DMSO concentrations on cell morphology.  
Note: Cell morphology was observed under a microscope with different DMSO 
concentrations. The micrograph shows that DMSO with 0.1% concentration has healthy 
cells with normal behavior, while a higher DMSO concentration presented cell death as 
shown in the image of the 1% group. 
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2.2.2.5: Monitoring HDPC Behavior in Primary and Secondary Passage  
 The primary cells culture took approximately 4 to 5 weeks to reach confluence. 
Once the cells were passaged, however, they grew at a much faster rate in the secondary 
passage, taking 7-14 days to reach confluence.  
In the present study there were different cell numbers obtained in the primary 
and second passages (Table 10). Under the inverted microscope, we examined the 
morphology of the cells growing from the explant in the previously described growth 
media.  
1) Round cells detached from the pulp explant day 6 of culture. These cells had a spherical 
morphology and sometimes appeared in clusters. (photo 17) 
2) First cell growth from the explants was noted on the 7th day. The cells that were round in 
shape began to have stellate appearance and elongated by parallel ordering to adhere 
close to the pulp fragment (photo 18). 
3) Cells surrounded the pulp explant in the 8th day, some of them displaying an elongated 
process, whereas young cells at the periphery of the cell outgrowth kept a fibroblastic 
shape (photo 19).   
4) The 9th day of tissue culturing revealed fibroblast-like, elongated, spindle-shaped human 
dental pulp cells that started to proliferate in a homogenous manner from the fibrillar 
projection in the pulp explant, arranged in a row (photo 20).  
5) After a period, which varied from 8 to 10 days, cells adhered to the plastic surface and 
became flattened with a smooth surface. Some cells exhibited thin processes (photo 21).  
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6) Pulp cells neatly emerging from the explant at 2 weeks of culture with typical fibroblast-
like morphology in 60% confluence (photo 22). 
7) After 3-4 weeks of culture, we estimate that the confluence of the cultures grown is 
between 70% and 100%. The cells expanded and formed condensed multilayered stripes 
of cell masses in colonies (photo 23). 
8) After the 70% confluence, the cells were detached by trypsin (photo 24). 
9) After 3 minutes in the trypsin, the cells were detached completely, floating in the flask 
and ready for seeding (photo 25). 
10) In the second passage when the cells were transferred after 24 hours, they were rounded 
and detached in the suspension; some of the cells were adherent, elongated into a spindle 
shape with thin expansion on the flask surface (photo 26). 
11) Within 2 days, the cells attached to the tissue culture flask and stretched out to spindle 
shape or more to fibroblast-like phenotype (photo 27).  
12) At the 7th day of the secondary passage the cells proliferated and duplicated in 
homogenous manner all over the flask surface (photo 28). 
13) The cell growth formed continuous sheets on the flask surface in about 2 weeks. In this 
time period cells reached 70-100% confluence (photo 29). 
14) Cells grew in growth media with TQ exhibited normal morphology and behavior (photo 
30). 
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Photo 17: HDPCs in the 6th day of culturing.  
Note: This is a photograph taken through the light microscope at 20x magnification, 
showing floating cultured HDPCs after 6 days of culture. These cells appear spherical.   
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Photo 18: HDPCs in the 7th date of culturing. 
 Note: This was taken through the light microscope at 20x magnification. It shows human 
dental pulp cells in the 7th day of culture. Cells began to have stellate appearance and 
elongate by parallel ordering to adhere close to the pulp fragment.  
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Photo 19: HDPCs  in the 8th date of culturing.  
  Note: The photograph was taken through the light microscope at 20x magnification.  
After the 8th day, the human dental pulp cells around the pulp explant displayed an 
elongated process, whereas young cells at the periphery of the cell outgrowth kept a 
fibroblastic shape.   
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  Photo 20: HDPCs  in the 9th day of culture. 
Note: The photograph was taken through the light microscope at 20x magnification. It 
shows human dental pulp cells appearing fibroblast-like, elongated, and spindle-shaped, 
starting to proliferate in a homogenous manner from the fibrillar projection in the pulp 
explant, arranged in a row.  
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Photo 21: HDPCs in the 8-10 dates of culturing. 
Note: This photograph, taken through the light microscope at 20x magnification, shows 
the dental pulp cells adhered to the flask surface. They became flattened and proliferated 
more in a period varying from 8 to 10 days.  
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Photo 22: HDPCs in 2 weeks of culturing. 
Note: The photograph taken through the light microscope at 20x magnification at 2 
weeks shows human dental pulp cells with typical fibroblast-like morphology, reaching 
60% confluence in cell culture.  
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Photo 23: HDPCs in 3-4 weeks of culturing 
Note: a photograph taken through the light microscope at 20x magnification in 3-4 weeks 
with confluence at 70–100% shows that cells expanded and formed condensed 
multilayered stripes.   
89 
 
 
Photo 24: HDPCs in trypsin.  
Note: The photograph was taken through the light microscope at 20x magnification after 
adding the trypsin. Cells started to detach from the surface. 
 
 
Photo 25: HDPCs detached completely after blocking the trypsin reaction.  
Note:  This photograph was taken through the light microscope at 20x magnification after 
splitting. The cells were detached completely from the surface and ready for seeding.  
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Photo 26: Round  shape of  HDPCs in the first 24h of transfer. 
Note: Taken through the light microscope at 20x magnification, the micrograph shows 
floating human dental pulp cells in second passage. The cell presented a round detached 
shape in the first 24h of transfer. Some of the cells are adherent, elongated in spindle 
shape with thin expansion on the flask surface.  
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Photo 27: HDPCs 2 days after secondary passage. 
Note: The photograph was taken through the light microscope at 20x magnification in 2 
days of the secondary passage. The cells attached to the tissue culture flask and stretched 
out to spindle shape or to a more fibroblast-like phenotype.  
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Photo 28: HDPCs in  7 days after secondary passage. 
Note: The photograph was taken through the light microscope at 20x magnification 7 
days after the secondary passage. The cells attached, proliferated and duplicated in a 
homogenous manner all over the flask surface.  
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Photo 29: HDPCs 2 weeks from the secondary passage. 
Note: This photograph was taken through the light microscope at 20x magnification after 
2 weeks from the secondary passage. The cell growth formed continuous sheets on the 
flask surface and reached 70-100% confluence.  
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Photo 30: HDPCs after seeding in 24-well tissue culture with TQ. 
Note: This photograph was taken through the light microscope at 20x magnification after 
seeding the cells in 24-well tissue culture plates with thymoquinone. Cells appeared 
normal with no changes in morphology or behavior. Arrows indicate the elongation 
process of thin fibroblast-like cells with triangular or stellate shape. 
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2.2.2.6: Cell number determination from primary, secondary passage and volume 
protocol 
 
 
Table 10: Cells numbers obtained from different flask sizes before cell seeding. 
 
 
 
Table 11: Volumes of materials for different cell culture conditions. 
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2.2.2.7: Determention of human Pulp cell attachment efficiency at different time 
intervals  
An attachment efficiency experiment was conducted to determine the normal 
behavior of human dental pulp cells in tissue culture media and to measure the 
attachment efficiency of the cells on plastic (surface of tissue culture wells with no TQ 
supplemented). To measure attachment efficiency, 1x105 cells were seeded on 5 wells of 
a 24-well plate for the following time intervals; 3 hours, 9 hours, 12 hours and 15 hours. 
Five supernates from each time interval were collected in 1.5 mL disposable tubes.  
The supernates contained floating, non-attached living cells. 40μL from the 
collected supernatants in each time point were loaded onto the Rechert-Jung 
hemocytometer.  The floating cells from each time interval were counted on the grid and 
recorded.  The 24-well plates were incubated in saturated humidity at 37°C and 5% CO2. 
Each plate per timeline was measured. A hemocytometer was used to count the floating 
cells for each time. 
The total cell number per mL of the suspension (X) was calculated using the formula:  
 
(Y) Is the sum of cells in all the four-hemocytometer squares that were counted. 
The number of cells counted was subtracted from the originally seeded cell number 
(1.0x105) and the calculated number was converted to percentage by dividing the two 
numbers and multiplying by 100. 
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 This gives us the estimated number of cells attached, considering 1.0x105 has 100% 
attachment efficiency.  
Attachment efficiency was calculated to establish a baseline of normal behavior 
for human dental pulp cells in the second passage of cell culture. Percentages are 
presented in the table below (Table 12). Based on the data from the experiment, it is 
concluded that all cells (nearly 99%) attach to tissue culture surfaces 15 hours after cell 
seeding. In addition, there were no higher cell numbers than the seeding concentration 
recorded. This indicates that there was no doubling up to the 15-hour point of the 
attachment experiment (Figure 5). The same tissue culture plates were used to perform 
another study by measuring the optical density from four wells in each time point with 
the attached cells. This was done to obtain a constant reference number for the attached 
cells. The plates were then stained with 0.2% crystal violate dye to stain the attached cells 
in the 24-well plates (photo 31), and to facilitate the determination of the optical density 
via the plate reader for each time period (Table 13). Then the optical density via the plate 
reader for each time period at a wavelength of 590 nm was determined.  Absorbance of 
crystal violet is directly proportional to cell numbers.  
In the present study the data showed that in 15h, the attached cell number is 
almost the same as the seeding number. Thus, the per-cell O.D is 0.38/105=0.038x 10-4. 
This was used as a reference number to determine the number of cells attached.  
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Photo 31: Crystal violet staining for attached cells.  
Note: Plates at different time points (3, 9, 12 and 15 hours) underwent Crystal violet 
staining for the attachment experiments (N=5). 
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Table 12: HDPCs attachment efficiency %. 
Note: This data represents human dental pulp cell attachment efficiency percentage at 
different time intervals up to 15 hours culture in tissue culture wells. (N=5 per time 
intervals). 
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Figure 4. HDPCs attachment efficiency against time. 
Note: Presented is a line curve of human dental pulp cell attachment efficiency 
percentage on tissue culture plates, up to 15 hours in culture. (N=5 per time intervals)  
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Table 13: OD of HDPCs at different per time intervals. 
Note: Data represents the optical density of human dental pulp cell at different time 
intervals up to 15 hours, cultured on tissue culture plates. (N=4 per time interval) 
 
  
102 
 
2.2.3:Assays of differentiation markers 
 
2.2.3.1: Alkaline phosphatase assay  
 
An alkaline phosphatase assay kit (Colorimetric) was purchased from Abcam to measure 
alkaline phosphatase activity in our biological samples (cell culture supernatants). 
Abcam's Alkaline Phosphatase Assay Kit is a highly sensitive, simple, direct and HTS-
ready colorimetric assay designed to measure alkaline phosphatase ALP activity in serum 
and biological samples. The kit uses p-nitrophenyl phosphate (pNPP) as a phosphatase 
substrate, which turns yellow (λmax= 405nm) when dephosphorylated by ALP. 
 
2.2.3.2: Dentin sialoprotein assay (ELISA) 
 
Human Dentin Sialoprotein Immunoassay (Quantizing ELISA) was purchased from US 
Biological Life Science to measure human dentin sialoprotein (DSP) levels in cell culture 
supernatants. A monoclonal antibody that is specific for human DSP is pre-coated onto a 
96 well microplate provided in this kit and was used for our experiment. Samples and 
standards were pipetted into the wells of the microplate. Any present DSP would bind to 
the antibody. Intensity of the color reflects the amount of DSP present in the samples and 
is measured using a microplate reader at a wavelength of 450 nm. 
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2.2.4: Experiments 
2.2.4.1: Cell attachment and proliferation evaluation, post TQ treatment with 
 Crystal violet staining  
This reliable screening method yields quantitative data that gives information 
about the relative density of cells adhering to multiple cell surfaces. This staining 
material, also called methyl violet, has histological applications for staining cells to 
determine cell attachment to various surfaces. This dye stains the cell’s DNA, depending 
on the solubilization of the amount of dye taken up by the monolayer of cells attached to 
a surface. Adherent cells detach from cell culture plates during cell death and are 
subsequently lost from the population of cells.  
The tests were performed at 16 hours, 7 days, and 21 days after seeding. The cell 
attachment and proliferation were evaluated by crystal violet staining. Cells were seeded 
onto 24-well plates at a density of 3×103 cells/well and containing 1 mL growth media 
for the control group or growth media with various supplemental TQ concentrations. The 
assay at each time point was repeated in triplicate. The culture plates were incubated 
under 37°C, 5% CO2 and all growth media were changed every 3 days. At each required 
time point, growth media was removed and cells were fixed with 10% neutral buffered 
formalin (Sigma) for one hour at room temperature. Fixer solution was then removed, 
plates were washed twice with 1x PBS and then stained with 1 mL 0.2% crystal violet 
stain (Sigma Aldrich)232 for 60 minutes at room temperature. The stain was prepared by 
`mL water). Unbound stain was removed by rinsing plates thoroughly with distilled water 
until the rinse was clear (photo 32).  
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Relative optical density was quantified using a microplate reader (TECAN, Infinite 
200 Pro) at 590nm wavelength. Absorbance of crystal violet is directly proportional to 
cell numbers after 16h of 100% cell attachment. Three measurements were performed 
and mean cell numbers were calculated. The cell number was calculated by using optical 
density measurements 
1. Per cell O.D = O.D reading- background / the initial seeding number (at 100% cell 
attachment) 
2. Cell number= O.D reading at each time point / per cell O.D. 
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Photo 32: Cell staining with crystal violet. 
Note: This picture presents the appearance of the crystal violet stained cells after fixation 
in their respective wells.  
.  
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2.2.4.2.1: Screening of odontoblast phenotypc markers for differentiation  studies  
At the 4th and repeated at the 18th day, the growth media were replaced by 
odontogenic media without vitamin D3. This is done one day (24 hours) before the 
addition of vitamin D3 to the odontogenic media, and prior to the collection of 
supernatant without vitamin D3. At these specific days, the old growth media were 
aspirated and the plates were washed with 1X PBS. Under sterile conditions, the growth 
culture media were replaced with odontogenic media without Vitamin D3 in all the TQ 
condition groups including the control group. This step was done to allow cells time to 
adapt to the odontogenic media for 24 hours. The Odontogenic media is made of 10% 
charcoal stripped FBS, 100 U/mL Penicillin G, 100 mg/mL Streptomycin, 10-8  M 
Menadione, 10 mM β-Glycerophosphate, 1.5 mg L-ascorbic acid and 2 mM L-Glutamine 
in plain BME media.  
On the 5th- 6th and repeated on the 19th- and 20th days, which correspond to two 
days (48 hours) prior to day 7 and 21 respectively, all odontogenic media without vitamin 
D3 was replaced by odontogenic media with 10nM vitamin D3.  This step was done in all 
the TQ condition groups including the control group. The supernates were harvested from 
all experimental groups at day 7 and 21. These supernatants from each plate were divided 
into multiple disposable 1.5mL sterile tubes, labeled according to the designed 
experiment and immediately frozen at -20°C (Photo 33). The corresponding plates were 
fixed and crystal violet staining was conducted to determine the cell number. Later these 
supernatants were analyzed as described in the next sections in the alkaline phosphatase 
activity experiment and for the DSP expression experiment.  
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Photo 33: Collected supernatant from different conditions at different time intervals. 
Note: This photograph was taken of the collected supernatant from different conditions 
and different time intervals. Day 7 (first raw ALP) and (second raw DSP), day 21 (third 
raw ALP) and (fourth raw DSP), and their control groups are in the same tube holder, 
labeled, frozen and ready for the differentiation studies.  
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2.2.4.3.1. Measurement of Alkaline Phosphatase Activity  
An alkaline phosphatase (ALP) assay kit (Colorimetric) was purchased from 
Abcam to measure alkaline phosphatase activity in the study cell culture supernatants. 
Alkaline phosphatase catalyzes the hydrolysis of phosphate esters in alkaline buffer and 
produces an organic radical and inorganic phosphate. Triplicate specimens were made for 
each group at time points of 7 and 21 days. Human dental pulp cells were cultured during 
this study with different TQ concentrations; 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as a 
control group, Ethanol and DMSO were vehicle controls. As mentioned above, two days 
before harvesting the supernates, at day 5 of cell culturing for the 7 days test plates for all 
groups, the odontogenic media without vitamin D3 was aspirated and replaced with 
odontogenic media with Vitamin D3 which was prepared in the lab according to protocol. 
The same steps were repeated at day 19 of cell culturing for the 21days test plates for all 
groups. 
The odontogenic media, as previously mentioned, consisted of 10% charcoal 
stripped FBS, Penicillin/streptomycin antibiotic 1:100 (v/v), Menadione (vitamin K) of 
10-8 M, β-Glycerophosphate 10 mM, 1.5 mg/mL L-ascorbic acid, L-glutamine of 2 mM, 
and 600 µL of Vitamin D3 giving an end concentration of 10nM, all in a calculated 
volume of BME plain media  (Table 7). At day 7, all supernatants with the added vitamin 
D3 from all plates were harvested in labeled disposable sterile 1.5 mL test tubes according 
to each TQ concentration.  The control group and vehicle groups were frozen for later 
assays. The same steps were done for the day 21 plates; the supernatants with vitamin D3 
were aspirated then placed in labeled disposable sterile test tubes according to each 
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condition and group then frozen. Both supernates collected from day 7 and 21 (Photo 33) 
were used for measuring the alkaline phosphatase activity by using the Colorimetric 
alkaline phosphatase assay kit. 
The Abcam’s (Colorimetric) alkaline phosphatase assay kit is a highly sensitive, 
simple, direct and HTS-ready colorimetric assay designed to measure ALP activity in 
serum and biological samples. The kit uses p-nitrophenyl phosphate (pNPP) as a 
phosphatase substrate, which turns yellow (λmax= 405 nm) when dephosphorylated by 
ALP. The Kit can detect 10-250 μU ALP in samples. Triplicate wells of differentiation 
media were used as the background, following manufacturer’s instructions. Using a 
standard clear flat bottom 96 well plate for the assay, samples and standard solutions 
were all placed in triplicate wells in the plate. 20 µL of stop solution was added as an 
initial step to terminate any reaction in the wells containing the background.  
2 tablets of pNPP were then dissolved into 5.4 mL Assay Buffer to make 5 mM of 
working solution. For standard curve preparation, 40 µL of the 5 mM pNPP solution was 
diluted with 160-µL Assay Buffer to generate 1 mM pNPP standard. By adding 0, 4, 8, 
12, 16, 20 µL of the 1mM pNPP standard prepared into the 96-well plate in triplicate, 
standards were generated for 0, 4, 8, 12, 16, 20 nmol/well. The pNPP standards were 
generated by bringing the final volume to 120 µL with Assay Buffer. Total volume for 
each sample well was brought to 100 µL according to manufacturer’s protocol. A volume 
of 20 µL from each sample collected in the test tube labeled with the condition/group and 
timeline was pipetted into its corresponding well in triplicate based on a template we had 
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formatted. 50 µL of 5mM pNPP solution was added to each well containing the samples 
and the background wells.  
10 µL of ALP enzyme solution was then added to the pNPP standard wells and 
thoroughly mixed. The ALP enzyme converted the pNPP substrate to an equal amount of 
colored p-Nitrophenol (PNP) (photo 34). Following this step the plate was covered with a 
clear plastic film and placed on an orbital shaker, then incubated for 60 minutes at 25°C 
in a dark environment by covering the plate with aluminum foil. The reaction was then 
terminated by 20µL stop solution, which was added to all wells, with the exception of the 
control, and the plate was shaken gently. Finally, using a microplate reader, all wells 
were measured for OD readings at a wavelength of 405 nm according to the 
manufacturer’s instructions.  
Mean absorbance measurement from the background control was subtracted from 
all sample readings. The mean absorbance reading of the 0 nmol standard was subtracted 
from the other standard readings for the corrected absorbance. The corrected absorbance 
measurements were then plotted as values of a final concentration of pNPP. The best-fit 
line that passes through the points was drawn using Microsoft Excel and a trend line 
equation based on our calculated standard curve. Using the equation generated from the 
standard curve, the amount of pNPP in all test samples of all groups was determined  
(y= 80.931x -0.02 with an R2 = 0.9939) by converting absorbance readings to alkaline 
phosphatase activity in µmol units. 
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Based on the formula provided in the calculation protocol, µmol units of pNPP 
divided by the sample volume (0.020mL) and divided by the reaction time (60 minutes) 
gives the alkaline phosphatase concentration in Units/mL.  
ALP activity (U/ML)=A/V/T 
 
Lastly, from measurements obtained from proliferation studies for cell numbers, the 
values of alkaline phosphatase activity for each sample were measured per million of 
cells. 
  
ALP activity (U/mL) = (Amount of pNPP generated from the sample (µmol) / 
volume of sample (mL)  / reaction time (minutes) 
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Photo 34: Activity of ALP on pNPP  
Note: The experimental mixture turned to yellow after adding pNPP as phosphatase 
substrate when dephosphorylated by ALP.  
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2.2.4.2.2: Measurements of DSP expression : 
Expression levels of secreted dentin sialoprotein were determined by the Dentin 
Sialoprotein assay (BioAssay™). It is a quantitative competitive enzyme-linked 
immunoassay technique. The kit contains a 96-well microplate pre-coated with a 
monoclonal antibody specific for human DSP. Supernatant samples and standards were 
pipetted into the wells. Any present DSP in the samples would bind to the antibody. 
The assay principle is to incubate the samples and standards together with DSP-
HRP conjugate for one hour. A competition for limited antibody binding sites on the 
plate occurs between DSP-HRP conjugate and DSP in the samples and standards. After 
the incubation period the wells are washed five times. The wells are then incubated with 
substrate for HRP enzyme. The products of the enzyme-substrate reactions form a blue 
colored complex. Finally, a stop solution is added to terminate the reaction, which will 
then turn the solution yellow. The intensity of color is measured spectrophotometrically 
at 450nm in a microplate reader. The intensity of the color is inversely proportional to the 
DSP concentration in the samples. The standards were prepared in concentrations of 0 
ng/mL, 1 ng/mL, 2.5 ng/mL, and 5 ng/mL. A standard curve is plotted relating the 
intensity of the color (O.D) to the concentrations of the standards. The DSP concentration 
in each sample is then interpolated from this standard curve. 
First, in a 96-well, pre-coated with antibody for human DSP microplate, triplicate 
wells were labeled, based on each TQ concentration and timeline at 7 and 21days. The 
supernatants that were tested came from TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM 
and 0 μM as control group, in either ethanol or DMSO. As mentioned previously two 
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days before harvesting the supernates, i.e. day 5 of cell culturing for the 7 day plates for 
all groups, the odontogenic media without vitamin D3 was aspirated and replaced with 
odontogenic media with Vitamin D3 that was prepared in the lab according to protocol. 
This was also done on day 19 for the 21 day plates of all groups. Also as described 
previously for alkaline phosphatase, the supernatant from all 7 and 21 day plates were 
collected and placed into disposable sterile test tubes that were labeled with condition and 
timeline (photo 33).  
The same odontogenic media, which was used with alkaline phosphatase 
experiments, was used in this experiment. It consists of 10% charcoal stripped FBS, 
Penicillin/streptomycin antibiotic 1:100 (v/v), Menadione (vitamin K) of 10-8 M, β-
Glycerophosphate 10 mM, 1.5 mg/mL L-ascorbic acid, 2 mM  L-glutamine , and 600 µL 
of Vitamin D3 giving an end concentration of 10nM (1:100), all in a calculated volume of 
BME plain media. Using a human DSP immunoassay (Quantikine ELISA) kit, DSP 
levels in the samples were measured.  
Initially, all supernates with various conditions were centrifuged for 15 minutes at 
1000 rpm to remove cellular particulates or debris (photo 35). Following the 
manufacturer’s recommendation, all reagents used for this ELISA were handled at room 
temperature. A total volume of 500 mL of wash buffer was prepared by adding 20 mL of 
the wash buffer concentrate to 480 mL autoclaved distilled water. Coated wells were 
secured in the holder then 100μL of the samples were added in the appropriate wells in 
the antibody pre-coated microtiter plate. Subsequently, 100μL of PBS (pH 7.0-7.2) was 
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added to the samples and to the blank wells. 10μL of balance solution was added to the 
100 μL sample of cell culture supernatant only, then mixed completely.   
50μL DSP-HRP conjugate was immediately added to each well (excluding the 
Blank well) followed by gentle agitation for thorough mixing. In this step the mixture 
color changed to light pink (Photo 36). The plate was then covered with a plate sealer and 
incubated for 1 hour at 37°C. The incubation mixture was then aspirated from each well 
to the waste container and wells were washed 5 times. The washing involved addition of 
about 400μL of 1x Wash Buffer using a multi-channel pipette. Each wash was allowed to 
sit for 15 seconds before being completely aspirated, and then the plate was inverted and 
taped against a clean absorbent paper towel until no moisture was present.  
50 μL of Substrate A followed by 50 μL of Substrate B were added to each well 
(including the blank). They were then gently agitated to ensure thorough mixing, leading 
to a color change to light blue (Photo 37).  After this step the mixture was incubated in 
the dark for 10-15 minutes at 37°C. Finally, the reaction was terminated by adding 50μL 
of stop solution to each well in the same order and timing as was the substrate solution. 
This turned the mixture color from blue to yellow (photo 38).  Immediately after 
completing the assay, the intensity of color was measured using the microplate reader 
(TECAN, Infinite 1000 Pro) at a wavelength of 450 nm. The intensity of color is 
inversely proportional to the DSP concentration in the sample or the standard. A standard 
curve was plotted relating the intensity of the color (O.D.) to the concentrations of the 
standards. 
116 
 
Using the mean values obtained from the standards after subtracting the 
background, a curve was generated using Microsoft Excel, and a log/log curve fit was 
determined. Mean absorbance for each concentration (y-axis) was plotted against the 
concentration (x-axis). The best-fit line passing through the points was generated on a 
logarithmic graph. From measurements obtained from proliferation studies for cell 
number for each time interval for day 7 and 21, the values of DSP reflecting its levels for 
each sample was calculated to obtain the concentration measured per million of cells. 
 Y= the value obtained from the optical density of the Elisa assay. 
 X= ng/mL  
 
Elisa formula: 
  
X=  _________-1_____________ 
            0.343X Log (Y/2.66) 
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Photo 35: Centrifugation of supernates. 
Note: Labeled supernates with various conditions were centrifuged for 15 minutes at 
1000 rpm to remove cellular particulates or debris.  
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Photo 36: Supernatants turn pink after adding DSP-HRP conjugate. 
 
 
Photo 37: Supernatants turn to light blue after adding substrate A and B.  
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Photo 38: Supernatants turn to yellow after adding stop solution.  
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Chapter Three: Statistical analysis   
 
Data are presented in means and standard deviations. Statistical significance is set at 
alpha p = 0.05. The means and standard deviations (SD) of human pulp cell attachment 
and cell proliferation rates at 7 and 21 days were calculated, in addition to levels of cell 
differentiation markers (alkaline phosphatase and dentin sialoprotein) at the same 
timeline. All data was analyzed using a one-way ANOVA test to compare the means of 
all study conditions groups at each timeline and Student’s t-test. The results were 
considered statistically significant at p<0.05. Statistical analysis was conducted using 
SAS software A (version 9.3; SAS institute, Cary, NC)  
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Chapter Four: Results 
 
4.1: Cell attachment efficiency at 16 hours with all TQ concentrations  
In a similar experiment, the study compared the attachment efficiency of human 
dental pulp cells in the 24-wells tissue culture plates in triplicate, with these TQ 
concentrations, 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control group at 16 hours after 
cell seeding. Seeding number was 3x103.  Analysis for cell attachment efficiency was 
performed as a baseline after 16 hours from cell seeding with 3x103 cells.  
 Cell attachments on the tissue culture plates were significantly greater in TQ 
concentrations among the groups (P= <0.0001) after 16 hours (Table 15). As shown in 
(tables 14, and 16), there were no significant differences in cell attachment between the 
control with a mean of 6.9 x10 4 cells and TQ =5 μM with its mean of 6.9 x10 4 cells (P = 
0.97). However, the data showed a significant increase in cell attachment for TQ =10μM 
with mean value 11.46 x10 4(P = 0.0009), TQ =15 μM, mean value 9.5 x 10 4 (P = 0.02), 
and TQ =30μM with mean value 12.9 x 10 4 (P = 0.003). 
It was observed that within this time period, cell doubling occurs. Cell attachment 
efficiency was significantly affected by TQ concentration 10 μM, 15 μM, and 30 μM 
tested in this experiment when compared to the control containing culture media without 
supplemental TQ. The differences are statistically significant indicating that the seeded 
cell number increased compared to the control group (Figure 6). 
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Table14: Mean values and SD for cell attachment efficiency at 16 h. 
Note: This data presents the mean values and SD of cell number attachment efficiency at 
16 hours with TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control pulp 
cells on tissue culture plates. (N = 3 per group).  
 
 
 
 
 
 
Table 15: P-Values for cell attachment efficiency in TQ concentrations at 16h.  
Note: The data presents the P- values of cell attachment at 16 hours with TQ 
concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control human dental pulp 
cells on tissue culture plates. (N = 3 per group). One-way ANOVA (P = <0.0001). 
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Table 16: P-Values for cell attachment efficiency compared to the control at 16h. 
 Note: Data represents the Student’s t-test P-Values of cell attachment efficiency at 
16 hours with TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control 
of human dental pulp cells on tissue culture plates. (N=3 per group).   
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Cell attachment efficiency at 16 hours with all TQ concentrations (N=3) 
 
Figure 5. Cell attachment efficiency at 16 hours with all TQ concentrations (N=3). 
 
Note: Normal human dental pulp cells were cultured for 16 hours with media containing 
supplemental TQ: 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as the control group. Highly 
Significant difference was observed among the groups (P<0.0001).  
 
★ Represent significant difference (p<0.05) compared to the control in each condition at 
the specified time point. 
 A yellow star represents significantly higher cell numbers compared to the control.  
 Error bars indicate the standard deviations of three replicates.  
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4.2: Proliferation rate affected by TQ with different concentrations at 7 and 
21 days.  
  To evaluate the effects of TQ on cell behavior, the same numbers of normal human 
pulp cells were cultured in 24 well plates containing culture media supplemented with 
various TQ concentrations. Cell numbers were determined at days 7 and 21 by using the 
optical density values measured from the microplate reader, and values were converted 
to cell number.  
4.2.1: Cell proliferation rate at 7 days with all TQ concentrations 
The ratio of cellular crystal violet stain to cell number has been determined from putting 
known cell numbers in plates and measuring the corresponding dye stain from those 
plates three times using the same and different seeding numbers of cells. The ratio 
(0.038) has been consistent and reproducible for all those measurements and therefore, it 
could be used to convert the optical density dye data to cell numbers with confidence. 
To determine the proliferation rates of norml human dental pulp cells  in media 
supplemented with TQ concentrations of 5 μM, 10 μM, 15 μM, 30 μM and 0 μM as 
control group for a time period of 7 days and 21 days, cell numbers at 16h were 
normalized as a baseline.  
 The proliferation rates was  calculated by dividing the cell numbers at 7 days and 21 
days by the cell numbers at  16 hours for each condition and then multiply by 100. The 
control cells were treated with growth media without supplemental TQ. At day 7, it 
showed that human pulp cells proliferated to a significantly higher degree in low TQ 
126  
concentrations compared to the control (Figure 7). TQ showed significant difference 
among the groups at 7 days depending on concentrations (P< 0.0001).  
The mean of proliferation rate in the control group was 41.5 percent. TQ =5 μM 
measured a mean prolifration rate of 56.6 percent (P=0.0005). Thats corresponds to a 
15% increase in the prolifration rate compared to the control group. However, there was 
no significant diffrance in cell prolifration rate compared to the control for TQ =10 μM, 
with mean 37.6 percent (P=0.2) and TQ =15 μM with a mean 37.8 percent (P=0.1). 
Notably, TQ =30 μM with mean prolifration rate 23.5 percent (P< 0.0001) 
showed a significant 18% decrease in the cell prolifration rates. 
Tables  18, 19 and 20 indicate that a lower TQ concentration could be beneficial 
for human dental pulp cell growth at 7 days. 
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Table 17: Mean values and SD of cell number x 104 at 7 days.  
Note: Row data presents the mean values and SD of cell numbers at 7 days with TQ 
concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control human dental pulp 
cells on tissue culture plates. (N=3 per group). 
 
 
  
Table 18: Mean values and SD of cell proliferation rates at 7 days. 
Note: Data presents the mean values and SD of cell proliferation rates at 7 days with 
tested TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM and 0 μM as control human dental 
pulp cells on tissue culture plates. (N=3 per group).  
Proliferation rates were calculated by dividing the cell numbers at 7 days by cell numbers 
at 16 hours for each condition and then multiply by 100. The control cells were treated 
with growth media without supplemental TQ.  
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Table 19: P-value of proliferation rates at day 7 among all the groups (ANOVA). 
 Note: Data presents the P-values of cell proliferation rates at 7 days with tested TQ 
concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control human dental pulp 
cells on tissue culture plates. (N=3 per group). One-way ANOVA (P= < 0.0001). 
 
 
 
 
Table 20: Proliferation rates at day 7 with tested TQ concentrations compared to the 
control (Student’s t-test). 
 
Note: Data presents the P-Values of cell proliferation rates at 7 days with tested TQ 
concentrations 5 μM, 10 μM, 15 μM, and 30 μM compared to 0 μM as control human 
dental pulp cells on tissue culture plates. (N=3 per group).  
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Cell proliferation rates at 7 days with all TQ concentrations (N=3) 
 
Figure 6.  Proliferation rates of normal human dental pulp cells in media supplemented 
with tested TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM and 0 μM as the control 
group for a time period of 7 days.  
 
Note: Proliferation rates were calculated by dividing the cell numbers at 7 days by cell 
numbers at 16 hours for each condition and then multiply by 100.  The control cells were 
treated with growth media without supplemental TQ.  
 
 ★ Represents significant difference (p<0.05) compared to the control in each condition at 
the specified time point. 
 The yellow star signifies a significantly higher proliferation rates compared to the 
control.  
 The Blue star represents a significantly lower proliferation rates compared to the control. 
 Error bars indicate the standard deviations of three replicates.   
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4.2.2: Cell proliferation rate at 21 days with all TQ concentrations (N=3) 
At 21 days (Figure 8), TQ showed significant difference in proliferation rates 
among the groups depending on concentrations (P< 0.0001). There was a decrease in 
proliferation rate in all TQ groups including the control at day 21. 
The mean of the proliferation rate in the control group was 38 percent. TQ =5 μM 
showed significant increase in proliferation rate compared to the control with an avarge 
cell prolifration rate of 40 percent (P=0.04). TQ =5 stimulates the proliferation process 
by 5% compared to the control.  
However, high TQ concentrations seemed to delay human dental pulp cells 
proliferation compared to the control group. The decrease in cell proliferation rate was 
noticed in the higher TQ concentrations, i.e., 10, 15 and 30 μM compared to the control 
group. TQ =10 μM with an avarge cell prolifration rate of 24.5 percent (P< 0.0001) and 
TQ=30 μM with an avarge prolifration rate of 21.3 percent (P< 0.0001). This corsponds 
to significantly higher decrease in prolifration rate, by 14% and 17% respectevely. 
However, TQ =15 μM with avarge prolifration rate 27.9 percent (P=0.0006), showed the 
significantly decreased proliferation rate of 11%. This observation is presented in (tables 
22, 23 and 24). 
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Table 21: Mean values and SD of cell number x104 at 21 days. 
Note: Row data presents the mean values and SD of cell numbers at 21 days with TQ 
concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control human dental pulp 
cells on tissue culture plates. (N=3 per group). 
 
 
Table 22: Mean values and SD of cell proliferation rates at 21 Days. 
 
Note: Data presents the mean values and SD of cell proliferation rates at 21 days with 
tested TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM and 0 μM as control human dental 
pulp cells on tissue culture plates (N=3 per group).  
Proliferation rates were calculated by dividing the cell numbers at 21 days by cell 
numbers at 16 hours for each condition and then multiply by 100. The control cells were 
treated with growth media without supplemental TQ  
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Table 23: P-value of proliferation rates at day 21 between all the groups (ANOVA). 
 Note: Data presents the P-values of cell proliferation rates at 21 days with tested TQ 
concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control human dental pulp 
cells on tissue culture plates. (N=3 per group). One-way ANOVA (P= < 0.0001). 
 
 
 
 
Table 24: Proliferation rates at 21 days with various TQ concentrations compared the 
control (Student’s t-test). 
 
Note: Data presents the P-Values of cell proliferation rates at 21 days with tested TQ 
concentrations 5 μM, 10 μM, 15 μM and 30 μM compared to 0 μM as control human 
dental pulp cells on tissue culture plates. (N=3 per group)  
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Cell proliferation rates at 21 days with all TQ concentrations (N=3) 
 
Figure 7: Proliferation rates of normal human dental pulp cells in media supplemented 
with various TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM and 0 μM as control group 
for a time period of 21 days.  
 
Note: Proliferation rates were calculated by dividing the cell numbers at 21 days by cell 
numbers at 16 hours for each condition and then multiplying by 100.  The control cells 
were treated with growth media without supplemental TQ.  
 
★ Represent significant difference (p<0.05) compared to the control in each condition at 
the specified time point. 
 The yellow star represents a significantly higher proliferation rates compared to the 
control.  
 Blue stars represent significantly lower proliferation rates compared to the control. 
 Error bars indicate the standard deviations of three replicates.   
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By normalizing the proliferation results on human dental pulp cells in media with the 
addition of TQ supplemented with tested concentrations 5 μM, 10 μM, 15 μM, 30 μM, 
and 0 μM as control group for a time interval at 7 and 21 days, it can be seen that the 5 
μM concentration result is significant at all the tested time intervels, i.e. 7days 
(P=0.0005) and 21days (P=0.04). This indicates that TQ =5 μM has the effect of 
increasing the cell proliferation rates  comparing to the control group throughout the 
proliferation experiment. The control group was treated with growth media without 
supplemental TQ (Figure 9). 
 
.  
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Cell proliferation rates at different time intervals 7 and 21 days (N=3) 
 
Figure 8: Proliferation rates results at different time intervals.  
Note: Comparison of proliferation rates of normal human dental pulp cells in media 
supplemented with tested TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM and 0 μM as 
control group for time intervals of 7 and 21 days.  
Proliferation rates were calculated by dividing the cell numbers at 7 and 21 days by cell 
numbers at 16 hours for each condition. The control cells were treated with growth media 
without supplemental TQ. 
 
 ★ Represent significant difference (p<0.05) compared to the control in each condition at the 
specified time point. 
 Yellow stars represent significantly higher proliferation rates compared to the control.  
 Blue stars represent significantly lower proliferation rates compared to the control. 
 Error bars indicate the standard deviations of three replicates.  
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4.3: ALP activity affected by TQ at different concentrations in tissue culture 
supernatants. 
4.4.1: Alkaline phosphatase activity at 7 days 
Results were observed at day 7 (Figure 10).  All the groups’ showed high 
statistically significant increase in ALP activity of the human dental pulp cells in 7 days 
(P=0.0001). The mean of ALP level in the control at 7 days was 0.04 mU/ml per million 
cells. 
ALP activity with high statistical significance in TQ=5 μM with mean 0.12 
mU/ml per million cells (P=0.001), TQ=15 μM with mean 0.12 mU/ml per million cells  
(P=0.0009) and TQ=30 μM with mean 0.14 mU/ml per million cells (P=0.001) was 
observed compared to the control group. However, significant increase in enzymatic 
activity was observed with TQ= 10 μM the mean was 0.10 mU/ml per million cells 
(P<0.05) in the odontogenic media compared to the control group (Tables 25, 26 and 27). 
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Table 25: Mean values and SD of ALP activity at day 7 in different TQ concentrations.  
Note: This data presents the mean and SD values of alkaline phosphatase activity at 7 
days with TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control pulp 
cells on tissue culture plates. (N=3 per group).  
 
 
 
 
 
 
Table 26: P-values for ALP activity at day 7 (ANOVA) 
Note: the data presents the P- values of alkaline phosphatase activity at 7 days with 
TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control pulp cells on 
tissue culture plates. (N=3 per group). One-way ANOVA  
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Table 27: P-values for ALP activity at day 7 in different TQ concentrations (Student’s t-
test). 
Note: Data presented is the P-values of alkaline phosphatase activity at 7 days of cells 
proliferation with TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control 
pulp cells on tissue culture plates (N=3 per group), (Student’s t-test). 
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Alkaline phosphatase activity at 7 days (N=3) 
 
Figure 9: Alkaline phosphatase activities at 7 days (N=3). 
 
Note: This is the alkaline phosphatase activity of normal human pulp cells in media 
supplemented with TQ concentrations 5 μM, 15 μM, 10 μM, 30 μM, and 0 μM as control 
group for a time period of 7 days. Alkaline phosphatase activity in supernates was 
normalized per million cells at each time interval. The control cells were treated with 
growth media without supplemental TQ.  
 
★ Represent significant difference (p<0.05) compared to the control in each condition at 
the specified time point. 
 Yellow stars represent significantly higher ALP activity compared to the control.  
 Error bars indicate the standard deviations of three replicates.  
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4.3.2: Alkaline phosphatase activity at 21 days  
At day 21 (Figure 11), the same group reached the highest value. All study groups 
showed significantly high increase in the rate of ALP activity (P<0.0001) among the 
groups.  The mean of ALP level at 21 days was 0.1 mU/ml per million cells. Data 
revealed that TQ concentrations in 5 μM with mean 0.21 mU/ml (P<0.0001), 10 μM with 
mean 0.18 mU/ml (P=0.003) and 30 μM with mean 0.17 mU/ml (P<0.0001) have the 
highest significant effect on ALP activity. At day 21 the 15 μM data presented significant 
increases in ALP activity compared to the control group with mean 0.12 mU/ml (p<0.05) 
as summarized in (tables 28, 29 and 30).  
 
  
141  
 
Table 28: Mean values and SD of ALP at day 21 in tested TQ concentrations.  
Note: Data shows the mean values and SD of alkaline phosphatase activity at 21 days 
with TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control pulp cells 
on tissue culture plates (N=3 per group).  
 
 
 
 
Table 29: P-values for ALP activity at day 21 (ANOVA).  
Note: Data illustrates the p- values of alkaline phosphatase activity at 21 days with TQ 
concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control pulp cells on tissue 
culture plates (N=3).  
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Table 30: P-values for ALP activity at day 21 in tested TQ Concentrations (Student’s t-
test). 
 
Note: Data shows the P-Values of alkaline phosphatase activity at 21 days with TQ 
concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control pulp cells on tissue 
culture plates. (N=3 per group), Student’s t-test.  
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Alkaline phosphatase activity at 21 days (N=3) 
 
Figure 10: Alkaline phosphatase activity at 21 days (N=3). 
 
Note: Depicted is alkaline phosphatase activity of normal human pulp cells in media 
supplemented with TQ concentrations 5 μM, 15 μM, 10 μM, 30 μM, and 0 μM as control 
group for a time period of 21 days. Alkaline phosphatase activity in supernates was 
normalized per million cells at each time interval. The control group was treated in 
growth media without supplemental TQ. 
 
★ Represent significant difference (p<0.05) compared to the control in each condition at 
the specified time point. 
 Yellow stars represent significantly higher ALP activity compared to the control.  
 Error bars indicate the standard deviations of three replicates.  
.
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 Alkaline phosphatase activity of normal human pulp cells in media supplemented 
with TQ concentrations of 5 μM, 15 μM, 10 μM, 30 μM, and 0 μM as the control group 
were analyzed between 7 and 21 days (figure 12). Alkaline phosphatase activity in 
supernates was normalized per million cells at each time interval.  
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Alkaline phosphatase activity at 7 and 21 days (N=3) 
 
Figure 11: Alkaline phosphatase activity at 7 and 21 days (N=3). 
Note: This is a comparison of alkaline phosphatase activity of normal human 
odontoblasts in media supplemented with TQ concentrations of 5 μM, 15 μM, 10 μM, 30 
μM, and 0 μM as a control group for a time period of 7 and 21 days. Alkaline 
phosphatase activity in supernates was normalized per million cells at each time interval. 
The control cells were treated with growth media without supplemental TQ.  
 
 ★ Represent significant difference (p<0.05) compared to the control in each condition at 
the specified time point. 
 Yellow stars represent significantly higher ALP activity compared to the control.  
 Error bars indicate the standard deviations of three replicates.  
.  
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4.4: Dentin sialoprotein expression in TQ at various concentrations  
 4.4.1: Dentin sialoprotein expression at 7days 
Dentin sialoprotein was measured from the supernatant culture medium collected 
from all 7 and 21 day plates using human Dentin Sialoprotein (DSP) BioAssay Elisa Kit 
(Human) US Biological Salem, MA. Data were expressed as total nanograms/mL of 
human DSP per million cells from supernatant solutions at 7 and 21 days. Dentin 
sialoprotein expression is an indicator of dentin differentiation. At the 7th day (Figure 
13) in the study the protein production of dentin sialoprotein was statistically 
significantly lower among all the study groups (P<0.0001) (table 31) and (table 32). 
Supernates collected at the 7th day showed significantly lower dentin sialoprotein 
phenotype excretion when compared to the non-treated group. The mean of DSP 
expression in the control group was 210 per million cells.  
TQ=5 showed significant decrease in DSP expression mean 134ng/ml per 
million cells (P=0.001). Similarly, TQ=10 μM DSP expression mean was 129ng/ml per 
million cells (P=0.002), TQ=15 μM DSP expression mean was 116.5ng/ml per million 
cells (P<0.0001) and TQ=30 μM DSP expression mean was 130.7 ng/ml per million 
cells (P=0.001) recorded significant effects on DSP (table 33). 
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Table 31: Mean and SD of DSP expression at 7 Days with various TQ Concentrations.  
Note: Data in this table are the mean values of dentin sialoprotein expression at 7 
days with TQ concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control pulp 
cells on tissue culture plates. (N=3 per group). The number is calculated per million 
cells. 
 
 
 
 
Table 32: P-values for DSP at 7 days with tested TQ concentrations (ANOVA ). 
Note: This data is the P- values of dentin sialoprotein at 7 days with TQ 
concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control pulp cells on tissue 
culture plates. (N=3 per group). One-way ANOVA (P<0.0001).   
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Table 33: P-values for DSP at 7 days with tested TQ concentrations (Student’s t-
test).  
 
Note: Data presented here are the P-values of dentin sialoprotein at 7 days with various 
TQ concentrations, 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control pulp cells on 
tissue culture plates. (N=3 per group). Student’s t-test.   
149  
Dentin sialoprotein expression at 7 days (N=3) 
 
Figure 12. Dentin sialoprotein expression at 7 days (N=3). 
 
Note: The figure presents dentin sialoprotein expression of normal human odontoblast in 
media supplemented with TQ concentrations 5 μM, 15 μM, 10 μM, 30 μM, and 0 μM as 
control group for a time period of 7 days. Dentin sialoprotein expression in supernates 
was normalized per million cells at each time interval. The control cells were treated with 
growth media without supplemental TQ. 
 
 ★ Represent significant difference (p<0.05) compared to the control in each condition at 
the specified time point. 
 Blue stars represent significantly lower Dentin Sialoprotein expressions compared to the 
control. 
 Error bars indicate the standard deviations of three replicates.  
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4.4.2: Dentin Sialoprotein Expression at 21days  
DSP expression at day 21(figure 14) for 5 μM, 10 μM 30 μM and 0 μM was 
statistical difference in protein production among the groups (P<0.5). The DSP expression 
mean for the control group was 280.8 ng/ml per million cells. 
Comparing all TQ groups 5 μM, 10 μM and 30 μM to the un-treated cells (P= 
0.66), (P= 0.07), (P=0.7) respectively. However, TQ =15 μM mean 213 ng/ml per million 
cells. was significantly lower than the untreated group (P<0.0001). Comparing the mean of 
the control group 280.0 ng/ml per million cells to TQ=5 μM 285.2 ng/ml per million cells 
and TQ=30 μM 286.8 ng/ml per million cells indicating that TQ affects human dental pulp 
cells by increasing slightly the DSP protein production. Further studies are recommended 
for longer times to measure the protein expression level after this time period. The findings 
at day 21 for the different concentrations are summarized in (tables 34, 35 and 36). 
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Table 34: Mean values and SD for DSP at tested TQ concentrations at 21 days.  
 
Note: The data reported here are the mean values of dentin sialoprotein at 21 days with TQ 
concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control pulp cells on tissue 
culture plates. (N=3 per group). 
 
 
 
 
 
Table 35: P-values for DSP at tested TQ concentrations at 21 days (ANOVA). 
 
Note: This data is the P- values of dentin sialoprotein at 21 days with TQ concentrations 
5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control pulp cells on tissue culture plates. 
(N=3 per group). One-way ANOVA (P=0.001).  
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Table 36: P-values for DSP for tested TQ concentrations at 21 days (Student’s t-test).  
Note: The data above are the P-Values of dentin sialoprotein at 21 days with TQ 
concentrations 5 μM, 10 μM, 15 μM, 30 μM, and 0 μM as control pulp cells on tissue 
culture plates. (N=3 per group). Student’s t-test. 
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Dentin sialoprotein expression at 21 days (N=3) 
 
Figure13. Dentin sialoprotein expression at 21 days (N=3). 
 
Note: Dentin sialoprotein expression of normal human odontoblast in media 
supplemented with TQ concentrations 5 μM, 15 μM, 10 μM, 30 μM, and 0 μM as control 
group for a time period of 21 days is shown above. Dentin sialoprotein expression in 
supernates was normalized per million cells at each time interval. The control cells were 
treated with growth media without supplemental TQ. 
 
 ★ Represent significant difference (p<0.05) compared to the control in each condition at 
the specified time point. 
 The blue star represents a significantly lower proliferation rate compared to the control. 
 Error bars indicate the standard deviations of three replicates.  
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Overall, dentin sialoprotein expression was increased on day 21 compared to its 
expression on day 7, which could be seen in (figure 15). However, there was statistical 
difference between all the TQ concentrations 5 μM, 15 μM, 10 μM, 30 μM and the 0 μM 
control group. However, it showed a slight increase (P= 0.66) in dentin sialoprotein 
expression on day 21 by the 5μM TQ group and (P= 0.71) by the 30 μM samples.  
It noticed that the increase in DSP expression from day 7 to 21days in the control 
group is 70 %. However, TQ= 5μM increased the DSP protein by 151% and TQ= 30μM 
increased the same phenotype by 156%. 
The data on day 7 and 21 indicate that the values of TQ 15 μM are double peak 
dose related. 
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Dentin sialoprotein expression at 7 and 21 days (N=3) 
 
Figure 14. Dentin sialoprotein expression at 7 and 21 days (N=3) 
 
 Note: The chart shows a comparison of dentin sialoprotein expression of normal human 
odontoblasts in media supplemented with TQ concentrations 5 μM, 15 μM, 10 μM, 30 
μM, and 0 μM as control group for time periods of 7 days and 21 days. Dentin 
sialoprotein expression in supernates was normalized per million cells at each time 
interval. The control cells were treated with growth media without supplemental TQ. 
  
 ★ Represent significant differences (p<0.05) compared to the control in each condition at the 
specified time point. 
 Blue stars represent significantly lower DSP expression compared to the control. 
 Error bars indicate the standard deviations of three replicates. 
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Chapter  Five: Discussion 
5.1: Introduction  
Pulp capping is a technique that is used to treat damaged pulpal tissues with the 
principle objective of promoting the regeneration of the dentin bridge through 
odontogenesis. The therapy aims to minimize and prevent injuries and damage that could 
result from the exposure of pulpal tissues to mechanical forces and chemical 
environments. Other elements likely to damage the exposed tissues include bacterial 
infections and thermal effects233.  
Unfortunately, so far, no optimal pulp capping materials with excellent long-term 
clinical outcome have been developed. In addition, none of the biomaterials currently 
available have been able to meet all the requirements of an ideal vital pulp therapy171. 
The process of development of the dental pulp is similar to the developmental pattern 
exhibited by the dentin, though the pulp mass becomes smaller with age due to the 
progressive deposition of dentin mass in the tooth. Internally, the pulp has three distinct 
zones which are the pulp core, the cell-rich zone and the cell free zone; the latter is 
constituted of capillaries and nerve networks which are essential for sensation and 
distribution of nutrients to the living tissues234. The primary living cells that require 
nutrients include the odontoblasts, fibroblasts, macrophages and plasma cells among 
others.  
The choice of the material for capping is critical. Some of the commonly used 
materials for dental capping include zinc oxide eugenol (ZOE), glass and resin-modified 
ionomers (GI and RMGIC), adhesive systems, and calcium hydroxide cement. ZOE is the 
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most commonly used capping material in dentistry but is controversially contraindicated 
by the cytotoxic nature of eugenol, which is thought to affect the pulp. Besides, ZOE is 
non-adhesive, hence a poor seal against corrosive compounds. GI and RMGIC are 
considered superior for lining deep cavities because they are biocompatible235. 
However, there are suggested cases of increased inflammation when GI and 
RMGIC are used, an observation associated with lack of reparative dentin bridge 
formation. The development of adhesive systems such as 4-META-MMA-TBB was 
viewed as an improvement of GI and RMGIC due to their hybridizing natures235; 
however, the adhesives promote vasodilation, which leads to dental bleeding. Also, the 
adhesives promote chronic inflammation besides being toxic to pulp cells. The other 
alternative that was developed is calcium hydroxide, an organometallic cement that has 
had its share of positives and negatives as a capping material235.  
While some conventional capping materials such as GI and RMGI have no 
documented cases of cytotoxicity, they have other weaknesses such as poor ability to 
promote cell adhesion and proliferation, which affect their suitability. Certain 
formulations of GI and RMGI might be toxic to the odontoblasts cells. As such, the 
choice of formulation that is used for pulp capping should be taken into account to 
prevent cytotoxicity 236. 
 The resin-modified formulations (RMGI) are considered more toxic than the 
conventional GI formulations. The formulations can, however, be used in deep cavity 
capping in spite of their potential toxicities. This is a result of the abilities of the 
formulations to interact with odontoblast cells to create a chemical bond that 
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subsequently prevents diffusion of the toxic compounds into the pulp through the dentin 
layer235. In the present study TQ showed that it does not have such complications and is 
more effective in promoting adhesion and proliferation of cells with certain 
concentrations. Therefore, it might offer better protection to human dental pulp cells and 
pulp tissue when used as a capping material. 
Thymoquinone, a new material, has shown osteogenic, anti-inflammatory, 
antibacterial, antioxidant, and analgesic effects, while having low impact on normal cells. 
Furthermore, it has shown promising ability to produce continuous layers of odontoblasts 
in an animal study7.  
All this inspired its usage as a pulp treatment agent on human dental pulp cells. 
The current study evaluated Nigella sativa seed extract, on human dental pulp cell 
attachment, proliferation and differentiation. Studies indicate that pulp capping can 
stimulate the formation of tertiary, reactionary and reparative dentin, which is key in the 
protection of pulpal tissues and cells228. There are multiple parameters that can be used to 
evaluate the effectiveness of pulp capping materials237.  
Some of the key parameters are, complete and partial formation of the dentin 
bridge, as well as the ability of the capping material to stimulate odontogenesis238. Ideal 
pulp capping material should have antibacterial action so as to disinfect underlying dentin 
and residual caries in deep caries lesions, be non toxic to the pulp cells, act as an 
analgesic, and induce the odontogensis process 170. 
The toxicity of TQ has been tested in multiple cell lines, both normal and 
malignant types. Studies suggest that TQ has limited cytotoxic effects on the cells. For 
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instance, Tubesha et al, highlight that TQ does not cause cytotoxicity in Sprague Dawley 
rats. The researchers in that study observed the effects of TQ treatment on the rats on day 
0 and day 14, revealing that a relatively high dose was required for any signs of toxicity 
to be exhibited. The study further showed that the toxicity of the drug is influenced by the 
body weight of the organism. In cases of toxicity, the effects can be overcome through 
consumption of water. Histopathological analyses also indicated that there probability of 
acute oral toxicity is very low under TQ treatment239.  
Advances in stem cell biology can be utilized to provide frameworks for the 
regeneration of endodontic tissues. Studies indicate that the most widely used bone 
marrow stem cells can differentiate into odontoblasts and subsequently form hard 
tissue240. In addition, dental engineering has successfully led to the isolation and 
characterization of dental pulp cells, which have subsequently been adopted for further 
engineering241.  
Major signaling molecules such as bone morphogenetic proteins BMP-2, 4,7, 
transforming growth factor-beta (TGF-b), and Heme oxygenase-1 enzyme have been 
shown to affect the differentiation of the dental pulp cells into odontoblasts242, 243. These 
findings suggest that the proliferation and differentiation of the cells can be initiated to 
regenerate the damaged tissues244.  
Among the pulp capping materials that been used, Calcium hydroxide is largely 
considered as the gold standard because of its superior antibacterial properties. Moreover, 
it is able to discharge bioactive molecules in the dentin matrix245. However, it does not 
stimulate dentinogenesis, thus leading to questions over its biochemical suitability for 
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pulp capping245, 246.  
Besides, histological analyses suggest that calcium hydroxide creates reparative 
dentin with tunneling defects, hence increasing the susceptibility of the pulp to long-term 
bacterial infections246. In addition, calcium hydroxide provides a poor seal, and its self-
cure preparations are soluble. Consequently, the capped zone is exposed over time thus 
promoting the reinfection of the cavity. Moreover, calcium hydroxide induces 
inflammation and is thus likely to affect the healing process, a factor that further affects 
its use243. 
Furthermore, it has a very high pH which is associated with necrosis at the wound 
site247. The drawbacks of calcium hydroxide are that it provides a poor seal, and it’s self-
cure preparations are soluble and exposed to dissolution over time 245. Because of its high 
pH level, a foci of necrosis forms at the wound site 247. Due to the demerits of calcium 
hydroxide, MTA became popular as an alternative. However, a recent Cochrane Review 
suggested that MTA might not be the ideal pulp capping material either, with concerns 
raised over its cost and setting time. However, MTA seems to have superior properties 
compared to Ca (OH)2 since it stimulates pulpal healing. Also, MTA provides a better 
seal and encourages dentin regeneration faster compared to Ca (OH)2
248, 249.  
Those superior properties could be attributed to a higher concentration of calcium 
ions which induce hard tissue formation250, facilitating the development of the dentin 
bridge within two weeks without significant cases of inflammation251. In spite of the 
strengths of MTA, it is difficult to handle and has a long setting time (approximately 23/4 
hours). It also leads to the discoloration of the tooth, is relatively expensive and highly 
161 
 
soluble, which limits its use252 253 254.  
Because of all the disadvantages researcher tend to investigate other materials that 
may be more biocompatible to the pulp. Due to the challenges and weaknesses exhibited 
by present man-made pulp capping materials, trying a natural therapy alternative was 
essential. Thymoquinone is the main active ingredient of Nigella sativa seeds, used for 
hundreds of years in the Mediterranean region and Western Asia. The compound has 
been widely explored in the recent past as interest grows over the potential of TQ, leading 
to the determination of its effectiveness against multiple pathological states255, 256. 
Thymoquinone is thus a good candidate to be reviewed as a probable alternative 
to the organometallic compounds. Some of the observed properties of thymoquinone are 
its anti-bacterial, anti-inflammatory activities, anticancer properties, analgesic and 
antioxidant ability, as well as being able to induce osteogenesis with fewer side effects 
while being non toxic to normal cells15. All the mentioned properties of TQ could make it 
a superior pulp capping material. Based on this premise, this study aimed to test for, and 
determine the impacts of various concentrations of supplemented TQ on normal human 
dental pulp cells  in terms of attachment, proliferation and differentiation. 
 The activities of the compound in the body depend on the physiochemical status 
of the body as well as the general environment within the body257. Conventionally, the 
chemical can influence the activities in both normal and abnormal cells, hence playing a 
role in the initiation or resolution of disease states. Some of the documented properties of 
TQ in the human body include anti-oxidant properties, anticancer, antimicrobial and 
gastroprotective characteristics. Also, TQ has shown significant ability to protect the 
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renal system against infections. Therefore, the seeds of Nigella sativa which are rich in 
TQ are pharmacologically used to treat diabetes, hypertension, bacterial infections and 
skin conditions among others 258. The effects of TQ can be noted not only in cancerous 
cells and tissues but also in normal cell lines from different organisms. 
The findings will subsequently promote professional changes in dentistry, leading 
to possible adoption of TQ as a pulp capping material. In spite of the potentials of TQ in 
dentistry, limited studies have tried to explore its biocompatibility and effects on human 
dental pulp cells. To implement this study towards the clinical aspect we tested TQ with 
different concentrations (5μM, 15μM, 10μM, and 30μM) on human dental pulp cells 
without isolating the stem cells.  Due to the explorative nature of this study on the effects 
of thymoquinone on human dental pulp cells, we compared TQ effects to other cell lines 
mainly, bone for the similarity between bone and dentin and its applications in treating 
disease. This was done along with comparing the response of the odontoblasts’ reaction 
to different pulp capping materials. 
Some of the tissues from which postnatal stem cells have been isolated for 
analysis include the skin, dental pulp, cornea, adipose tissue, umbilical cord, and bone 
marrow259 ,260, 87, 261, 262,263, 264, 265, 266. These studies have since shown that human pulp-
derived stem cells have high proliferation and multi-lineage differentiation rates 
compared to other types of stem cells. The advanced plasticity and abundance of the 
HDPCs make them suitable for tissue engineering which is the foundation of pulp 
capping267.  
The current study uses dental pulp tissue obtained from human healthy third 
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molars to isolate HDPCs. The rationale behind the choice of the third molar is that they 
are more proliferative since they are the last teeth to erupt in the oral cavity. In addition, 
the cells of the third molar are considered to be relatively undifferentiated87. Also, Atari 
et al. recommends the use of the third molars as sources of HDPCs, noting that they 
exhibit the greatest multi-lineage diversity in their differentiation potentials268. Data from 
this study on normal human dental pulp cells were more clinically relevant compared to 
data from previous studies, which utilized HDPCs and animal-derived odontoblasts. With 
this purpose, this study assessed the odontogenic potential effect on human dental pulp 
cells by evaluating alkaline phosphatase activity and dentin sialoprotein expression as 
specific markers of human dental pulp cells differentiation.  
There are two primary approaches that can be used to isolate HDPCs from pulp 
tissue. Based on previous studies, the two adoptable techniques include the explant 
outgrowth approach and the collagenase digestion method269 260, 270, 271 272, 273. In the 
current study we have used the explant outgrowth techniques leading to the isolation of 
the cells on the basis of their morphological features, that is the fibroblast-like cells and 
the stellate types (photo 6). 
 
5.2: Thymoquinone and HDPCs behavior: 
A number of studies have focused on the toxicity of thymoquinone on cancer 
cells274, 275. The studies show that TQ protects against oxidative damages caused by 
hydrogen peroxide. Thymoquinone has protective effect against hydrogen peroxide H2O2 
induced oxidative damage and increased the survival of cells. Hence, this compound 
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renders protection to cells exposed to oxidative stress by protecting normal cells from 
oxidative damage276. Toxicological analyses have also suggested that TQ as well as other 
extracts from the plant have negligible levels of toxicity13.  
The effects of TQ are not limited to the cancer cells. Studies have also revealed 
the activity of the phytochemical on damaged organs. For instance, Hosseini et al, point 
out that the phytochemical can play restorative roles on ethanol-damaged organs14. Since 
the ethanol acts through the release of the ROS leading to lipid peroxidation and 
apoptosis, TQ can be used to manage this sequence of events and reverse their impacts. 
Also, TQ can reduce the production of pro-inflammatory cytokines while simultaneously 
affecting concentrations of critical enzymes in the body system. Some of the enzymes 
that the study highlights as affected by the TQ concentrations as ALP, aspartate 
transaminase, and alanine transaminase. The activation of caspases is also affected by TQ 
concentration14.  
In this study the cells morphology and behavior were closely monitored from the 
first day in the primary passage to the end of the secondary passage to adding the TQ to 
the cells. This to detect any alteration in the cells morphology or behavior. The current 
study indicated that no cells morphology changes on human dental pulp cells after adding 
TQ (photo 30). The cells shape and behavior were maintained throughout the entire 
experiment comparing to the control group with all the tested TQ= 5 μM, 15 μM, 10 μM 
and 30 μM. Beside the cells morphology, the cells attachment and proliferation were 
assessed to determine the TQ effect on human dental pulp cells.  
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5.3 Attachment efficiency of HDPCs after adding TQ at16 hours  
Adhesion is an important step at the beginning of cell–material interaction, and is 
also a foundation for cell growth, proliferation and differentiation. In this study, human 
dental pulp cells were chemotactically attracted and grew with the added thymoquinone. 
The concentration of the phytochemical can dictate its effects on the targeted cell lines 
277.  
The current study indicates that the concentration of TQ does affect the 
attachment of human dental pulp cells. TQ concentrations used were 5μM, 10μM, 15μM, 
and 30μM, with a control of 0μM. Since optimal attachment occurs after 16 hours of 
exposure, the analysis of the effects of the concentrations on the attachment of TQ was 
carried out for 16 hours and the number of attached human dental pulp cells determined 
in comparison to the control. 
The analysis showed that there was higher attachment when relatively high 
concentrations were used. Specifically, the study showed that highest attachment was 
realized with a TQ concentration of 30 μM. Based on the findings that human dental pulp 
cells respond positively to treatment with TQ, possible effectiveness of the natural 
chemical as a pulp capping material is indicated. Analysis of variance showed that 
attachment of human dental pulp cells treated with TQ was significantly higher than the 
control group. Low concentrations of TQ (5 μM) had no effect on attachment compared 
to the higher concentrations as determined in the study. 
According to Ji et al., calcium hydroxide is used as a direct pulp capping material 
due to its potential to induce the repair of hard tissues. As such, it is expected that the 
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paste can help to regenerate the hard tissue above the exposed pulp. The study further 
highlights that odontoblasts are lost due to the extensive damage that occurs in the 
exposed area. Therefore, the use of the paste protects odontoblast cells by shielding them 
from direct exposure to chemical and biological agents that are likely to initiate cell 
death278. Ji et al. focused on dental pulp stem cells (DPSCs) and indicated that STRO-1 
and CD146 were involved as mesenchymal stem cell markers. Moreover, the study points 
out that calcium hydroxide increased the recruitment, migration, proliferation and 
mineralization in periodontal tissues278.  
However, past studies have not compared the differentiation impacts of calcium 
hydroxide and TQ. The current study indicates that TQ has similar effects on 
differentiation, proliferation and attachment of cells. The findings also confirm that the 
human dental pulp cells are highly responsive to TQ, and that its protective properties 
could make it a superior alternative to the conventional calcium hydroxide paste.   
Recent study tested TQ toxicity with a concentration of 10μM compared to the 
control and they reported no significant difference on MC3T3-E1 bone cells. Also, to 
generalize their result the test was repeated on 3T6 fibroblast cells. It showed that both 
TQ and its vehicle did not affect the impedance of fibroblasts when compared to the 
control. From all the above they concluded that TQ is not toxic to the cells225.  
Chu, S. C., et al, their results showed that the 24 h treatment with TQ at various 
concentrations elicited significant concentration-dependent cytotoxic effects on various 
oral cancer cell lines. No significant inhibitory effects were observed in a normal human 
gingival epithelial S-G cell50  
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Similarly, MTA used as pulp-capping material showed low cytotoxicity to the 
odontoblasts cells while the induction of proliferation could be the factor behind the 
regeneration of the dentin bridge in instances of MTA-mediated direct pulp capping. This 
suggests why MTA is a superior pulp capping material compared to Dycal279, 280. 
Vaillancourt et al., tested TQ cytotoxicity on fibroblast-like synoviocytes at 
different concentrations (0–10 μM) and determined that it did not alter cell viability281. 
In contrast, where published in vitro studies that suggest that Dycal has potential 
cytotoxic effects on HDPCs243, such as promoting necrosis and chemical injuries to the 
cells and tissues282-285, that it affects the healing process and the regeneration of the 
dentin bridge249 as well as having high pH which affects the suitability of Dycal as a pulp 
capping material, TQ does not interfere with the biological functions of the cells since it 
has limited effects on the pH and cell environment. 
 
5.4: Proliferation of HDPCs at 7, 21 days: 
Multiple studies have shown that TQ has anti-proliferative effects, can induce cell 
cycle arrest and also induces pro-apoptotic effects in cancer cells274, 286. Numerous 
sources also point out that thymoquinone can inhibit cancer cell migration, proliferation, 
invasion, angiogenesis and tube formation both in vivo and in vitro287-289. 
Alhosin et al. also stated that TQ concentrations higher than 10μM target the anti-
apoptotic UHRF1 gene leading to the initiation of apoptotic cell death. In addition, the 
studies showed that TQ generates intracellular ROS, which is associated with cell cycle 
arrest due to DNA damage. The arrested cells subsequently undergo apoptosis due to the 
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activation of the p73-dependent cell cycle signaling pathway. It also leads to the down 
regulation of H2O2-induced 4-hydroxynonenal
288. 
Vaillancourt et al., studied the anti-proliferative effects of TQ in 
lipopolysaccharide (LPS)-treated human experimental models of rheumatoid arthritis 
fibroblast-like synoviocytes. When the cells were treated with 10μM TQ, there was a 
20% decline in cell growth compared to lipopolysaccharide-treated cells. The authors 
inferred that the moderate reduction in cell proliferation could be attributed to the low 
dose of TQ281.  
An anti-proliferative action of TQ would be helpful since rheumatoid arthritis is 
characterized by tumor-like expansion of the synovium from proliferation in 
synoviocytes and infiltration of leucocytes290.  
On the other hand, TQ alone exerted considerable cytotoxicity against UMSCC-
14C cells, while it induced a weaker killing effect against normal oral epithelial cells 
(OEC) in low concentrations291.  
Interestingly, TQ induces and up regulates cell proliferation in other cell types 
and normal cells with certain concentration ranges and time considerations225. In the 
current study the effects of TQ concentrations on cell proliferation was evaluated. The 
time taken for the cells to proliferate when TQ is used was also determined, with the 
analyses of the cultures being reviewed at 7 and 21 days. 
The analyses showed that the rate of proliferation of human dental pulp cells 
increased significantly with lower concentration of TQ (=5 μM) by 15% at 7 days and 
5% at 21 days, compared to the control. The positively influenced proliferation and 
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uprequlating effect caused by thymoquinone may serve as a first indicator of the 
odotoinductive properties of thymoquinone in human dental pulp cells. 
The data also revealed that the rate of proliferation of human dental pulp cells 
decreased significantly with high TQ (=30 μM) by 18% at 7 days, and 17% at 21 days 
compared to the control. This indicates that high TQ concentrations could have cytotoxic 
effects on human dental pulp cells. 
Between the low TQ concentration (5 μM) and the high TQ concentration (30 
μM), the prolifration rate decreases with time. The intermediate concentrations (TQ =10 
μM and TQ=15 μM)  showed no effect on the prolifration rate. However, with time they 
exhibited a significant decrease in prolifration rate compared to the control. 
This result was consistent with comparing the effect of TQ on cell proliferation 
rates to other pulp capping materials. According to Al-Shaher et al., there is an inverse 
relationship between dental pulp cells’ viability and propolis concentration. Treatment of 
PDL fibroblasts with 1, 2, or 4 mg/ml propolis resulted in increase 75% to 44% PDL cell 
viability after 20 h 282.  
Similar results to the present study were reported by Salim et al., They assessed 
an acute lymphocyte leukemic cell line (CEMss) with an IC50 of 1.5 μg/mL and 
concluded that the proliferation of TQ-treated cells decreased as the TQ concentration 
increased292. 
Counter to the present study, André Wirries at al., evaluated different TQ 
concentrations on osteoblast cell proliferation at different time intervals (24, 48 and 72 h 
post treatment). Cells treated with TQ 1 μM and 5 μM did not affect the growth of the 
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cells. On the other hand, higher concentrations of TQ (10–40 μM) significantly induced 
the growth of MC3T3-E1 cells at 24, 48 and 72 h of incubation225. 
Another study performed by Ecevit et al., evaluated the effect of TQ on the 
viability of bronchial epithelium cell line BEAS-2B. Their study showed significant 
increases in cell proliferation with high TQ concentrations (10-80 μM) at 24,48 and 72 
hours293. 
In contrast with MC3T3-E1 and BEAS-2B cells, human dental pulp cells were 
significantly down regulated by high TQ concentrations (10 μM, 15 μM, 30 μM) in 21 
days when compared to the control. However, there were significant increases in cell 
proliferation with TQ =5 μM in 7 and 21 days. This affirms that low TQ concentration 
promotes faster proliferation of the cells which leading to subsequent differentiation and 
regeneration of the tissues of the human dental pulp. 
Studies by André Wirries et al. and Ecevit et al. have limitations, since they 
evaluated the TQ effect on cell proliferation for less than 7 days, and therefore the 
proliferative effect of the TQ supplements on the cells in later stages was not recorded225. 
Studies in mice suggest that the LD50 for the phytochemicals is relatively high, 
averaging 104.7mg/kg following intraperitoneal injections, and 794.3mg/kg for oral 
ingestion. However, the lethal dose of TQ in cancer cells is significantly lower, the 
approximated LD50 being <10mg/kg. Therefore, the phytochemical can effectively be 
used to prevent carcinogenesis while encouraging regeneration and proliferation of 
normal cells at significantly low concentrations42, 294.  
Comparative analysis of the effects of MTA and calcium hydroxide on human 
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dental pulp cell proliferation showed that Mineral trioxide aggregate significantly 
stimulated cell proliferation after 12 days, whereas Dycal had no such effect250. 
Moreover, studies indicate that MTA increases biocompatibility and proliferation while 
reducing the rate of apoptosis243, 279. 
 Recent in vitro studies have also indicated that the proliferation of human dental 
pulp cells is dependent on time, with MTA and PC having greater effects on proliferation 
within the first week compared to Dycal which records lower numbers of cells than the 
control group. This observation suggests that Dycal has inhibitory effects which affect its 
suitability as a pulp capping material295. In contrast, in our study dental pulp cell 
proliferation was noted in the 7th day and at 21 days after adding TQ =5 μM, which 
indicates that TQ induces cell proliferation with low concentration.  
 
5.5: Differentiation of HDPC at 7 and 21 days. 
5.5.1: Alkaline phosphatase (ALP) 
During dentin formation, odontoblast cells synthesize and secrete several 
noncollagenous proteins into the dentin extracellular matrix 228. Among these, dentin 
sialoprotein DSP and alkaline phosphatase ALP are considered to play a regulatory role 
in the mineralization of reparative dentin and are therefore considered as specific markers 
for the odontoblast phenotype228. ALP is an early marker, whereas osteocalcin (OCN) is a 
later marker for odontoblast differentiation296, 297. Dentin sialophosphoprotein (DSPP) is 
odontoblast specific and is expressed by terminally differentiated odontoblasts during the 
late stage of dentin matrix mineralization298. 
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A study on the change of ALP activity in cultured dental-pulp cells found that 
ALP activity peaked at the turning point of the proliferation and differentiation phases. 
That study indicated that ALP activity is a marker for the initial differentiation of 
odontoblasts299. Alkaline phosphatase is a pre-osteoblastic key marker that is abundantly 
expressed at early stages of osteogenic differentiation and is responsible for bone 
mineralization300. In turn, to identify the anabolic activity of TQ on dental pulp cells 
differentiation, the current study further evaluated the effect of TQ concentrations 5 μM, 
to 10 μM, 15 μM, and 30 μM TQ on the expression levels of alkaline phosphatase as 
differentiation markers essential for odontoblast cells differentiation. 
André Wirries et al., evaluated the effect of thymoquinone on MC3T3-E1, the 
cells were treated with 10 μM TQ for 6, 24, and 48 h to assessed alkaline phosphatase 
ALP, differentiation markers essential for osteoblast differentiation. Their results showed 
that alkaline phosphatase resulted in a 2-fold increase in the mRNA expression of ALP, 
when compared to the control group in 24 hours and a significant increase in alkaline 
phosphatase induced 48 h post TQ-treatment225. Similarly, in the present study our results 
showed a significantly higher increase in alkaline phosphatase as a differentiation marker 
in the entire time interval we designed for this study, 7 and 21 days. These significant 
increases in alkaline phosphatase activities were expressed in all TQ concentrations, 5 
μM, to 10 μM, 15 μM, and 30 μM. The up-regulation of alkaline phosphatase may 
provide strong evidence of the odontogenic differentiation potential of the studied human 
dental pulp cells.  
The aim of the present study was to analyze, in vitro, the odontogenic effects of 
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TQ using human dental pulp cells. The present study data showed for the first time, a 
direct stimulating effect of TQ on human dental pulp cells as evidenced by its ability to 
increase the expression level of ALP, which is a marker for differentiation. An increase in 
alkaline phosphatase is an early marker for odontoblast differentiation301. Similar 
findings were reported by Wang et al. who demonstrated an important role of the active 
cellular NF-κB pathway in the up-regulation of alkaline phosphatase and the formation of 
the bone-like hard tissue bridge in injured dental pulps of rats 302 Additionally, human 
dental pulp cells were found to have strong osteogenic differentiation potential when 
isolated from the healthy pulp of exfoliating primary teeth302.  
The nature of the hard tissue bridge that forms following pulp capping is not fully 
recognized. Histological studies have revealed that the hard tissue may have multiple 
perforations and can be described as dentin-like, or bone-like, and as a reparative dentin 
bridge 303. The levels of alkaline phosphatase ALP and other enzymes have been shown 
to respond to thymoquinone concentrations. According to Helal et al., Thymoquinone has 
multiple pharmacological effects on liver cells, a factor that affects the concentrations of 
alkaline phosphatase enzymes released by the cells304. Also, another study suggested that 
TQ could have protective effects against hepatotoxicity and oxidative stress induced by 
sodium fluoride. The study further points out that NaF impairs liver functions by 
increasing the levels of ALP, AST, ALT and LDH. Treatment of the affected patients 
with TQ administered orally at a dose of 10 mg/kg for 5 weeks results in normalization of 
the enzyme levels hence a reversal of the pathological states305. 
A similar study confirms the TQ effect on controlling alkaline phosphatase 
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release to control diseases. The authors indicated that daily oral administration with TQ 
of TQ 5 mg/kg was found to have significant protective effects by decreasing the 
enzyme’s levels, which indicate bone turnover, in comparison to the rheumatoid arthritis 
rats281. Our results are also in agreement with another study, which evaluated the effect of 
MTA on gingival and periodontal ligament fibroblasts. The study by Bonson et al. 
demonstrated up-regulation of osteogenic markers such as alkaline phosphatase, 
osteonectin, osteopontin, and osteonidgen, which may contribute to hard tissue matrix 
formation and/or mineralization306. In contrast to our study Shiwei Cai et al., reported 
MTA and Dycal inhibited ALP expression, in dental pulp cell cultures in the presence or 
absence of bacterial infection compared to the control group, whereas, Portland cement 
(PC) demonstrated an initial stimulation and later suppression295. Alkaline phosphatase 
activity is required for mineral deposition in dentinal collagen sheets 307. In this study, 
alkaline phosphates activity was increased by day 21, which is in agreement with other 
studies that suggested that alkaline phosphatase plays a role in the organism’s reaction to 
injury. Increased ALP gene expression in vitro has also been observed in other studies 
after MTA and Biodentine stimulation 307, 308.  
 The present study findings suggest that TQ could be advantageous in the long-
term for conservative pulpotomy or pulp capping treatment to offset the high cost of 
MTA material. However, further studies are needed to determine the exact role of  
mineralization protein and the signaling pathways that are activated to initiate 
mineralized tissue formation.  
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5.5.2: Dentin sialoprotein (DSP) 
In order to achieve a better understanding of human dental pulp cells 
differentiation, the current study investigated the DSP phenotype created by human 
dental pulp cells in TQ concentrations 5 μM, 10 μM, 15 μM, and 30 μM. Human dental 
pulp cells have osteogenic/odontogenic differentiation potential. They can differentiate to 
osteoblast-like or odontoblast-like cells, which indicate the type and configuration of the 
hard bridge layer formed throughout the repair process.  
There are multiple aspects that can affect the differentiation method of human 
dental pulp cells, including the donor’s condition, age, cytokines, cell injury, passage 
number, and presence of chemical substrates such as pulp capping materials 302, 309. 
Furthermore, the physical and chemical properties of dentin collagen are similar to 
collagen within bone and both are especially adapted for binding matrix proteins and 
mineral deposition 310, for this reason it could be a possible deposition of bone-like tissue 
over mechanically exposed pulps. 
The effects of other pulp capping materials are also explored by Koike et al., who 
indicate that the ultimate goal of capping is to regenerate the dentin bridge. However, 
Koike et al. suggest that different capping materials have distinct effects on the 
regeneration of dentin, with particular effects on Dentin phosphoprotein (DPP) showing 
significant variations. The study showed that the reparative dentin formation induced by 
the DPP/collagen composite occurs at the same rate as calcium hydroxide after three 
weeks. However, the initial stages suggested that the composite recorded faster 
regeneration compared to the calcium hydroxide cement311.  
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Koike et al. further showed that DPP/Collagen composites could be used as better 
pulp capping materials than calcium hydroxide pastes due to their superior abilities to 
initiate the regeneration of the dentin bridge311.  
The current study also highlights that TQ could be a superior alternative to 
calcium hydroxide. It highlights the need to adopt the phytochemical due to its limited 
side effects and superior qualities as a potential pulp capping material.  
According to the present study results, it is interesting to know that the expression 
of DSP was significantly down regulated in relation to the control in the 7 day samples of 
all TQ concentrations 5 μM, 10 μM, 15 μM, and 30 μM.  However, human dental pulp 
cells surprisingly reacted with TQ to produce DSP expression and start to differentiate 
the same as the control group in 21 days except for TQ=15 μM. There was similar DSP 
expression mean between the 21 day samples of TQ concentrations 5 μM, 10 μM and 30 
μM and the control group. In this study the level of DSP expression is considered as time 
dependent. 
The increase in DSP expression per million cells was different from various TQ 
concentrations from 7 days to 21 days. With TQ =5 μM, the increase in DSP level was 
151%, with TQ =10 μM was 124 %, and for TQ=30 μM was 156 %, whereas for TQ =15 
μM and the control group, the increase in DSP expression from 7 days to 21 days was 
close, which are 97% and 70 % respectively. TQ =5 μM which increased DSP level from 
7 days to 21 days by 151% and that may increase more in later time. Thus a longer study 
for one week is recommended to evaluate the effect on DSP expression of the TQ 
concentration.  
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The choice of a pulp capping material is also largely influenced by the formation 
of the dentin bridge, which is also linked to dentin sialoprotein. Analyses of the cements 
currently available for use indicate that calcium hydroxide paste and MTA are able to 
stimulate the regeneration of the dentin bridge312.  
Also, MTA is shown to positively influence the secretion of DSP and heme 
oxygenase. However, the duration required for the formation of the dentin bridge and for 
the odontoblasts to secrete DSP is longer when conventional cements are used compared 
to the period taken to secrete DSP when TQ is used. This observation by Min et al. 
suggest that TQ could be a better pulp capping material than both calcium hydroxide and 
MTA312.  
Regarding the undetectable expression of odontogenesis markers, the unexpressed 
DSP at 7 days was comparably explained in a similar study, which showed undetectable 
DSPP, since DSP is the N-terminal domain of DSPP. The study evaluated MTA and 
propolis’ effect on human dental pulp cells. Their result showed that MTA and propolis 
enhance the osteogenic differentiation potential of the cells in all tested groups compared 
to the control group. MTA and propolis appeared to up-regulate the odontogensis 
markers (BMP-2, ALP, RUNX-2 and OCN), however, DSPP expression was 
undetectable in all studied groups. The author suggests that the deposition of bone-like 
tissue over mechanically exposed pulps could be the reason313.  
Yan et al., study reported up-regulation of odontogenic and osteogenic markers 
(RUNX-2, OCN, DSPP and DSP) in apical papilla stem cells treated with MTA, which 
may indicate that MTA may stimulate odonto/osteoblastic differentiation314, however, in 
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injured dental pulps, human dental pulp cells may preferentially differentiate toward 
osteoblast-like cells302.  
Dental pulp stem cells from traumatically exposed pulps exhibited an enhanced 
osteogenic potential and weakened odontogenic capacity310. In addition, the isolated 
human dental pulp cells, as in the present study, are comprised of a mixed population of 
cells rather than purely odontoblast progenitor cells270.  
The present study findings are in disagreement with previous studies that have 
demonstrated DSPP gene expression in human dental pulp cells treated with MTA and 
enamel matrix derivative315. In the present study, TQ showed delay differentiation in 
human dental pulp cells by exhibiting DSP expression in 21days. This correlates with the 
findings of a previous study, which tested simvastatin statin, and 3-hydroxy-3-
methylglutaryl coenzyme, a reductase inhibitor, which is known to promote bone 
formation in human dental pulp stem cells. With different concentrations in vitro and in 
vivo, DSPP is expressed in a time dependent manner316, 317.  
The same study, on rat incisor dental pulp cells, showed that ALP activity peaked 
on day 5 in a b-GP (þ) culture, while Ca2þ accumulation started at culture day 15299. By 
contrast, the increase in expression of the DSPP gene coincided with initial 
dentinogenesis, and thus was a marker for odontoblast maturation140, 318, 319. Also, 
formation of calcifying nodules by human dental pulp culture has been found to occur 
between day 10 and 15 of culture319. Additionally, previous studies have shown that 
DSPP gene expression was up-regulated not only in odontoblasts forming primary dentin 
but also in odontoblast-like cells forming reparative dentin145.  
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Latest study identified that MTA and Dycal inhibited DSPP expression in dental 
pulp cell cultures in the presence or absence of bacterial infection compared to the 
control. However, PC demonstrated general stimulation of DSPP expression in the same 
conditions, which indicates that MTA had an inhibitory effect on human dental pulp cell 
differentiation295. Parirokh et al., considered this as a drawback of MTA besides it’s long 
setting time, alkaline pH, or presence of toxic elements191.  
The capability of TQ to prompt the expression levels of early, intermediate and 
late differentiation markers with it is antibacterial effect indicates that TQ can be used for 
intervention at various stages from the early to the late phase of the differentiation 
process. In addition, the fact that TQ showed early and late proliferation with low 
concentrations makes this material a promising natural therapeutic drug.  It shows great 
potential to expand the odontogensis process and treatment.  
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Conclusions 
 The results of this study indicated that Thymoquinone (TQ) supplements with certain 
concentrations significantly enhanced cell attachment, proliferation and alkaline 
phosphates activity of human dental pulp cells. There was statistically significant 
increase in cell attachment efficiency at 16 hours in the TQ = 10 μM, 15 μM, and 30 μM 
study groups.  
 Cell proliferation rates increased with lower TQ concentration  (TQ = 5 μM) at 7 and 21 
days, however, cell proliferation rates decreased with higher TQ concentration   (TQ = 
30 μM) at 7 and 21 days.  
 TQ with all the tested concentrations 5 μM, 10 μM, 15 μM, and 30 μM, at 7 and 21 days 
increase the alkaline phosphatase (ALP) activity. 
 TQ with all the tested concentrations, 5 μM, 10 μM, 15 μM, and 30 μM significantelly 
down requlated Dentin sialoprotein (DSP) expression at 7 days. However, at 21 days 
only TQ =15 μM significantelly down regulates DSP. 
 From the results of the present study, it was concluded the 5μM TQ supplemented 
concentration would significantly up-regulate proliferation rates, ALP activity at 7 and 
21 days and no effect in DSP expression at 21 days of normal human dental pulp cell 
culture.  
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 This is the first report to investigate the optimal TQ concentrations needed to induce 
human dental pulp cell attachment, proliferation and odontogenic potential. This might 
lead to development of new odontogenic treatments having clinical applications.  
 
Clinical considerations 
From this finding, the study suggested a potential clinical benefit for treating 
human dental pulp cells with TQ as a pulp capping material. 
This is evident from the increased proliferation and differentiation of dental 
pulp cells on the TQ =5 μM group. Also, the observed significant increase in alkaline 
phosphatase activity may translate clinically to an enhancement of human dental pulp 
cell differentiation and potential odontogenesis. This will result in a better healing 
outcome and longer tooth survival. 
 Future implementation of TQ in dental pulp capping materials may help to 
improve direct pulp capping, pulpotomy procedures, decrease its failure rate and may be 
a useful therapeutic agent for pulpal repair. 
This is the first report to investigate the optimal TQ concentrations in each 
aspect of inducing human dental pulp cell attachment, proliferation and odontogenic 
potential. This might lead to development of clinical applications. 
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Future Studies: 
 This study showed that thymoquinone with concentration 5 μM would up-regulate 
proliferation at 7 and 21 days.  An in vitro study with lower TQ concentrations is 
recommended to evaluate the proliferation and differentiation. 
 Human dental pulp cells showed an increase in DSP expression in a time related manner 
with the TQ concentration 5 μM, 10 μM and 30 μM at day 21. A longer study is 
recommended to assess the effect of TQ on DSP expression. 
 Furthermore, this study demonstrated the effect of TQ on non-infected human dental pulp 
cells. Future studies are required for evaluating the effect of TQ on contaminated human 
dental pulp cells. This is to evaluate the antibacterial effect and odontogenic effect of TQ 
on human dental pulp cells.  
 In addition, further studies are necessary to determine the degradation rate of 
thymoquinone-containing biomaterials to achieve the optimal in vivo concentrations of 
released thymoquinone, which can induce odontogenesis.  
 Animal studies will also be required to obtain necessary data leading to future clinical 
applications of novel thymoquinone-containing odontogenic materials.   
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